A Place for Sexual Dysfunctions in an Empirical Taxonomy of Psychopathology

A Place for Sexual Dysfunctions in an Empirical Taxonomy of Psychopathology

Sex Res. Author manuscript; available in PMC 2018 May 1.
Published in final edited form as:
J Sex Res. 2017 May; 54(4-5): 465–485.

Published online 2017 Jan 25. doi: 10.1080/00224499.2016.1269306

PMCID: PMC5433908
NIHMSID: NIHMS854523
PMID: 28121167
Miriam K. Forbes,1 Andrew J. Baillie,2 Nicholas R. Eaton,3 and Robert F. Krueger4

Abstract

Sexual dysfunctions commonly co-occur with various depressive and anxiety disorders. An emerging framework for understanding the classification of mental disorders suggests that such comorbidity is a manifestation of underlying dimensions of psychopathology (or “spectra”). In this review, we synthesize the evidence that sexual dysfunctions should be included in the empirical taxonomy of psychopathology as part of the internalizing spectrum, which accounts for comorbidity among the depressive and anxiety disorders. The review has four parts. Part 1 summarizes the empirical basis and utility of the empirical taxonomy of psychopathology. Part 2 reviews the prima facie evidence for the hypothesis that sexual dysfunctions are part of the internalizing spectrum (i.e., high rates of comorbidity; shared cognitive, affective, and temperament characteristics; common neural substrates and biomarkers; shared course and treatment response; and the lack of causal relationships between them). Part 3 critically analyzes and integrates the results of the eight studies that have addressed this hypothesis. Finally, Part 4 examines the implications of reconceptualizing sexual dysfunctions as part of the internalizing spectrum, and explores avenues for future research.

 

Introduction

Symptoms of sexual dysfunctions1—or low sexual function— broadly include low or absent sexual desire, difficulty becoming and/or staying sexually aroused, difficulty attaining orgasm, or experiencing rapid orgasm, and sexual pain (American Psychiatric Association [APA], 2013). Low sexual function is not only common —with an estimated prevalence of about 40–45% for women and 20–30% for men (Lewis et al., 2010)— it is often associated with marked personal distress (Hayes et al., 2008; Lewis et al., 2010), relationship distress (e.g., Bossini et al., 2014), low self-esteem (e.g., McCabe & Althof, 2014), and decreased quality of life (e.g., Bossini et al., 2014; Laurent & Simons, 2009). Despite this, low sexual function is rarely considered as an indicator of psychological functioning beyond the specialized field of sex research.

While sexual dysfunctions are independently associated with negative outcomes, they also commonly co-occur with emotional disorders, such as depressive and anxiety disorders (Laurent & Simons, 2009) and this comorbidity can have a particularly detrimental impact. For example, comorbidity between sexual dysfunctions and emotional disorders is associated with higher rates of suicidality, as well as increased chronicity and severity of the disorders, relative to either cluster of disorders alone (e.g., Dell’Osso et al., 2009; Michael & O’Keane, 2000; Rajkumar & Kumaran, 2015). When the disorders are not treated together, this comorbidity is also associated with worse long-term treatment outcomes, such as higher dropout, poorer response, and poorer adherence (e.g., Bossini et al., 2014; Dobkin, Leiblum, Rosen, Menza & Marin, 2006; Laurent & Simons, 2009). Given their strong negative impact when combined, more research is needed to understand the nature of the relationships between sexual dysfunctions, emotional disorders, and psychopathology more broadly. Characterizing the nature of these relationships is key to gaining insight into low sexual function, and is a prerequisite for understanding the mechanisms and processes that underlie comorbidity, which is necessary for effective diagnosis and treatment.

In this review, we propose that while there has been limited research that has explicitly addressed the question of how and where sexual dysfunctions fit into the bigger picture of psychopathology, a synthesis of the extant literature suggests we may already have an answer. Some readers may be skeptical about integrating sexual dysfunctions into a model of psychopathology because variations in sexual response are not necessarily indications of pathology within a person; rather, they can be normative or adaptive reactions to current circumstances, such as a particularly stressful period or relationship difficulties (Bancroft et al., 2003b). However, when low sexual functioning persists without a clear cause (e.g., not due to a non-sexual mental disorder, substance misuse, a medical condition, inadequate sexual stimulation, or severe partner distress; APA, 2013), it can become problematic. For example, when these experiences cause distress in the form of worry, anxiety, or disruption to nonsexual aspects of a relationship, there is a need for support and/or intervention (Balon, Segraves & Clayton, 2007). Indeed, this is how the Diagnostic and Statistical Manual for Mental Disorders (DSM) defines clinically significant distress, and delineates the threshold on the range of sexual experience that distinguishes between ‘normal’ and ‘disordered’ sexual function (Stein et al., 2010)2.

Rather than stigmatizing experiences of low sexual function as ‘mental disorders,’ or endorsing the DSM’s putatively narrow, categorical, and prescriptive definitions of sexual experience (cf. Moynihan, 2003; Tiefer, 2002), our review aims to elucidate an empirically supported understanding of the psychological aspects of sexual function in a descriptive psychopathology framework. That is, we aim to gain new insight by synthesizing current knowledge of the empirical relationships between the features of experiences like depression, anxiety, and low sexual function as they co-occur, which can clarify the path to understanding their etiologies. This approach does not rely on a reductive view of sexuality by defining it as a purely psychological experience; rather, it allows for the roles of many other processes involved in the profoundly complex experience of sex and sexuality (e.g., biological and medical vulnerabilities, social context, and environmental factors), which are often conceptualized in a biopsychosocial framework (e.g., Black, 2005; Tiefer, 2002; Wincze & Weisberg, 2015).

Our review has four parts: In Part 1, we briefly explore current thinking about the structure of psychopathology, and describe the current structural model that has been derived from the systematic patterns of comorbidity among mental disorders. In Part 2, we review the prima facie evidence supporting the formation of the hypothesis that sexual dysfunctions should be included in this structure as part of the internalizing spectrum. In Part 3 we review the preliminary studies that have addressed this hypothesis. Finally, in Part 4 we discuss the implications of this idea and avenues for future research.

Part 1: Current thinking about the structure of psychopathology

Common mental disorders are significantly correlated and have consistently been found to co-occur at higher rates than would be expected by chance (Kessler, Chiu, Demler & Walters, 2005; Kessler et al., 1994). These patterns of comorbidity between mental disorders have been an ongoing difficulty for psychopathology research since the release of the third edition of the DSM because they highlight the lack of distinction of disorders as diagnostic categories (Kessler et al., 2005). To learn how we can best conceptualize these patterns of co-occurrence among mental disorders, we need to understand how and why disorders covary. One way to understand comorbidity among a group of disorders is to determine which statistical models offer the strongest explanation of empirical data that document the comorbidity (Krueger & Markon, 2006).

Studies that have statistically analyzed the patterns of co-occurrence among symptoms of mental disorders have consistently found that the best explanation for these patterns is the presence of shared underlying factors (dimensions, or “spectra”) that are transdiagnostic —that is, they cut across traditional diagnostic boundaries and represent the stable core psychological processes shared by groups of disorders (Achenbach & Edelbrock, 1978, 1984; Markon, 2010; Wright & Simms, 2015). For example, in early work on adult psychopathology, Clark and Watson (1991) proposed a tripartite model to account for the comorbidity between anxiety and depression: The overlap between these disorder constructs is accounted for by a general heritable factor they term neuroticism —with a defining characteristic of negative affect (see Andrews, Morris-Yates, Holt & Henderson, 1990)— and they are distinguished by unique factors of anxious arousal (specific to anxiety) and anhedonia or low positive affect (specific to depression).

With a broader focus on the comorbidity among a variety of mental disorders, Krueger and colleagues (1998) found evidence of two correlated spectra of psychopathology that describe the structure of common mental disorders (see Figure 1): The externalizing spectrum accounts for the comorbidity among substance use disorders and antisocial behavior, where disinhibition is prominent; and the internalizing spectrum accounts for the comorbidity among depression, anxiety, and other disorders characterized by prominent negative affect and distress. The internalizing spectrum splits into fear and distress sub-factors in many structural studies, which primarily differentiate between disorders with fear-based characteristics (e.g., phobias, social anxiety) and with sadness/worry-based characteristics (e.g., major depression, generalized anxiety disorder [GAD]) respectively (Eaton, Rodriguez-Seijas, Carragher & Krueger, 2015a; Eaton, South & Krueger, 2010; Krueger & Markon, 2006). This descriptive structure groups disorders according to actual empirical relationships, rather than through the focus on shared phenomenological features in the DSM (Krueger, Markon, Patrick & Iacono, 2005). Through use of factor analytic techniques, researchers can separate the correlations among disorders that indicate the latent comorbidity spectra (e.g., what major depression has in common with GAD) from the disorder-specific variance that indicates the uniqueness of each disorder (e.g., what makes major depression different from GAD and all other internalizing disorders) (Krueger & Piasecki, 2002). The resulting internalizing-externalizing model of common mental disorder comorbidity is consistent with current genetic and personality research and has been replicated across sociodemographic groups, cultures, diagnostic time frames, at various measurement levels, using a variety of analytic approaches, and for clinical and community samples (see Carragher, Krueger, Eaton & Slade, 2015; Eaton, 2014; Eaton et al., 2015a).

An external file that holds a picture, illustration, etc. Object name is nihms854523f1.jpg
Figure 1

An example of the internalizing-externalizing model of common mental disorders based on Krueger (1999). MDD = major depressive disorder; GAD = generalized anxiety disorder; AUD = alcohol use disorder; DUD = drug use disorder; ASPD = antisocial personality disorder. In this model the rectangles represent observed variables (e.g., DSM diagnoses rated as present or absent), which act as indicators for the latent variables (i.e., the ellipses). Each latent variable represents the shared variance among its indicator variables, and these relationships are represented by the single-headed arrows. Double-headed arrows represent correlations between variables.

The discovery of internalizing and externalizing spectra in adult psychopathology has fostered a rapidly growing literature on the underlying hierarchical and dimensional structure of psychopathology. A Hierarchical Taxonomy of Psychopathology (HiTOP) has subsequently been established to integrate the vast body of research that has tested factor analytic models of dimensional spectra into a single descriptive model of the meta-structure that includes 11 of the 19 DSM chapters, and six spectra, including internalizing and externalizing (Kotov et al., under review).

Utility of the spectra

While the label “internalizing disorders” can be used simply to refer to the disorders that indicate the latent internalizing spectrum —for example, as a collective label for depressive and anxiety disorders3— the spectra of psychopathology also convey a wealth of information beyond descriptive labels for groups of symptoms and disorders. The internalizing spectrum, for example, can be thought of as a continuous underlying dimension of risk where someone with a high level of internalizing is likely to experience multiple chronic and severe internalizing symptoms (e.g., symptoms of depressive and anxiety disorders) over their lifetime, and someone with a low level of internalizing may not experience any symptoms (e.g., Krueger & Finger, 2001; Krueger, Markon, Patrick, Benning & Kramer, 2007). The spectra also represent the conceptual overlap between the disorders, capturing their shared processes and mechanisms, and acting as channels for core psychopathological processes (Forbes, Tackett, Markon & Krueger, 2016). For example, spectra can account for the roles of genetic and environmental risk and protective factors, predict disorder onset, course and treatment response, and predict adaptive functioning (Eaton et al., 2015a; Kessler et al., 2011; Kim & Eaton, in press; Krueger & Eaton, 2015; Lahey, Zald, Hakes, Krueger & Rathouz, 2014; Rodriguez-Seijas, Stohl, Hasin & Eaton, 2015). These spectra also frame the development of psychopathology across the lifespan, and can act as a bridge between multiple streams of research (e.g., nosological research, developmental psychopathology research, neuropsychology research, and clinical practice; Forbes et al., 2016; Kotov et al., under review). As such, the empirically derived spectra of psychopathology offer ideal phenotypes to frame future research. As a result of the findings that dimensional spectrum models offer the best explanation of the broad structure of psychopathology, spectra of psychopathology have been incorporated into the DSM-5 to reflect the empirical relationships and similarities between larger groups of disorders (e.g., the Depressive Disorders and Anxiety Disorders chapters are adjacent; APA, 2013).

Many analyses of the structure of psychopathology have relied upon datasets from large epidemiological surveys. These data sets are strong in their sheer size and in the quality and hence representativeness of their sampling. Unfortunately, sexual dysfunctions are almost invariably excluded from epidemiological research on psychopathology, and as a result sexual dysfunctions have not been included in any of the large-scale analyses of the structure of mental disorders (Kendler, 2009; Krueger, Watson & Barlow, 2005; Markon, 2010). Sexual dysfunctions have been tentatively included in HiTOP as part of the internalizing spectrum based on work by Forbes and colleagues on self-report data from convenience samples (Forbes, Baillie & Schniering, 2015a, 2015b, 2016; Forbes & Schniering, 2013), which are reviewed in detail in Part 3. However, empirical evidence for the inclusion of sexual dysfunctions in HiTOP is at the lowest standard (i.e., emerging evidence with scant validation; Kotov et al., under review), and they are at risk of being left behind.

While the HiTOP model is based on the results of studies that have empirically analyzed the factor structure of the descriptive features of psychopathology (Kotov et al., under review), an earlier framework outlined a substantive approach with which to build hypotheses about the classification of mental disorders into spectra in the lead-up to the DSM-5 (Andrews et al., 2009). The APA Diagnostic Spectra Study Group of the DSM-5 suggested eleven criteria to support the validity of a spectrum: (1) comorbidity, (2) abnormalities of cognitive/emotional processing, (3) temperamental antecedents, (4) treatment response, (5) symptoms, (6) neural substrates, (7) biomarkers, (8) illness course, (9) genetic risk factors, (10) familial risk factors, and (11) environmental risk factors. Part 2 will review evidence in this framework that supports the formation of the hypothesis that sexual dysfunctions are part of the internalizing spectrum. We will focus primarily on the phenotypic features of low sexual function beyond shared symptoms (i.e., comorbid disorder presentation; and cognitive, emotional, temperamental, and affective features), and touch briefly on neurobiological and psychophysiological factors, but we will not discuss genetic, familial and environmental risk factors because there is scant direct evidence in this area. Part 3 will then review the studies that have tested the hypothesis that sexual dysfunctions are part of the internalizing spectrum.

Part 2: Evidence that supports the formation of the hypothesis that sexual dysfunctions are part of the internalizing spectrum

While specific manifestations of internalizing are phenotypically distinguishable, they are proposed to be maintained by similar processes, such as a prominence of negative affect, and aversive reactions to negative affect that often include situational, cognitive, and behavioral avoidance (Allen, McHugh & Barlow, 2008; Barlow et al., 2010). There is currently evidence that a variety of DSM-5 disorders may be manifestations of the internalizing spectrum, including: depressive and anxiety disorders, obsessive-compulsive and related disorders, trauma and stressor-related disorders, bipolar and related disorders, somatic symptom disorders, and feeding and eating disorders (Kotov et al., under review). Many of these disorders share traits like repetitive negative thinking, perfectionism, and emotion avoidance (Barlow et al., 2010; Ehring & Watkins, 2008; Mills et al., 2016). Notably, symptoms of these disorders have multifaceted relationships with low sexual function, which are explored below. For the sake of brevity, Part 2 will focus on the relationships between diagnoses and symptoms of sexual dysfunctions and the core internalizing disorders (i.e., depressive and anxiety disorders), starting with the common patterns of comorbidity.

Comorbidity

Internalizing disorders have long been known to have high rates of co-occurrence with sexual dysfunctions (Derogatis, Meyer & King, 1981; Kaplan, 1979; Wolpe, 1958). Over the last thirty-five years (i.e., since the release of DSM-III), a vast body of research has consistently found systematic patterns of comorbidity between internalizing disorders and sexual dysfunctions, and these findings have been documented in detail elsewhere (e.g., Atlantis & Sullivan, 2012; Laurent & Simons, 2009). To briefly offer some specific examples, diagnoses and symptoms of major depressive disorder, GAD, panic disorder, obsessive-compulsive disorder (OCD), and posttraumatic stress disorder have been found to have multifaceted relationships with lower sexual desire, arousal, and orgasmic function for men and women, as well as with sexual pain for women (e.g., Aksaray, Yelken, Kaptanoglu, Oflu & Ozaltin, 2001; Althof et al., 2005; Balon, 2006a; Breyer et al., 2014; Cheng, Ng & Ko; Figueira, Possidente, Marques & Hayes, 2001; Hirsch, 2009; Kaya et al., 2006; Kendurkar & Kaur, 2008; Rajkumar & Kumaran, 2015; van Lankveld & Grotjohann, 2000; van Minnen & Kampman, 2000; Vulink, Denys, Bus & Westenberg, 2006). Social anxiety has been found to have more specific relationships with orgasmic disorders and erectile function in men (Bodinger et al., 2002; Corretti, Pierucci, De Scisciolo & Nisita, 2006; Figueira et al., 2001; Tignol, Martin-Guehl, Aouizerate, Grabot & Auriacombe, 2006), but also with desire, arousal, and pain disorders in women (Bodinger et al., 2002; Corretti & Baldi, 2007; Figueira et al., 2001). A small subset of studies has found mixed results (e.g., Dèttore, Pucciarelli & Santarnecchi, 2013; McCabe & Connaughton, 2014) or results contrary to the patterns described above (e.g., Munoz & Stravynski, 2010). However, these findings represent a small minority of the body of research, and are outweighed by the consistent and frequently replicated findings of comorbidity in the extant literature.

The high rates of comorbidity between sexual dysfunctions and internalizing disorders are particularly striking in the absence of overlapping symptoms (vs. between depressive and anxiety disorders, for instance, which have some overlapping diagnostic criteria; APA, 2013), and have been replicated across demographic groups, and in populations from most cultures around the world (e.g., Laurent & Simons, 2009). Further, these relationships hold independent of the side effects of medication4 (Aksoy, Aksoy, Maner, Gokalp & Yanik, 2012; Araujo, Durante, Feldman, Goldstein & McKinlay, 1998; Baldwin, 2001; Bodinger et al., 2002; Breyer et al., 2014; Kennedy, Dickens, Eisfeld & Bagby, 1999; Nicolosi, Moreira, Villa & Glasser, 2004; Vulink et al., 2006; Williams & Reynolds, 2006).

Shared cognitive and emotional processes

Looking beyond the high comorbidity rates among sexual dysfunctions and internalizing disorders, there is a large body of literature highlighting parallels in their cognitive and affective processes and characteristics. For example, people with hypoactive sexual desire disorder, and men with erectile dysfunction or premature ejaculation share the same difficulty in identifying and communicating emotions (i.e., alexithymia; Madioni & Mammana, 2001; Michetti et al., 2007) that is common in emotional disorders like depression and anxiety (Marchesi, Brusamonti & Maggini, 2000).

Nobre and colleagues built on Barlow’s (1986) model of sexual response, and their work highlights detailed evidence for consistency between the cognitive and emotional processes in low sexual function that mirror cognitive models of depression and anxiety (cf. Beck, 1974, 1979). For example, the three key processes highlighted in SexLab’s work on the cognitive and affective features of low sexual function are: (1) people with sexual dysfunctions have unrealistic and inflexible beliefs about sex (e.g., a real man should be able to get an erection whenever he wants to); (2) when negative sexual events occur that are inconsistent with these beliefs, negative sexual self-schemas develop (e.g., I’m not a real man), which (3) generate negative automatic emotions and thoughts (e.g., I’ll never be able to get an erection) that interfere with sexual response as part of an ongoing cycle that maintains low sexual function (Nobre & Pinto-Gouveia, 2009; Oliveira et al., 2014; Oliveira & Nobre, 2013b; Peixoto & Nobre, 2014, 2015; Quinta Gomes & Nobre, 2012).

There are striking similarities between these three processes in sexual dysfunctions and internalizing disorders. Sexual dysfunctions are characterized by the same sorts of unconditional beliefs (e.g., conservative, unrealistic, rigid, and/or negative ideas about sex; Bach, Wincze & Barlow, 2007; Dosch, Belayachi & Van der Linden, 2016; Nobre & Pinto-Gouveia, 2006a, 2008a, 2009; Peixoto & Nobre, 2014; Sbrocco & Barlow, 1996; Strub, 2013) that act as vulnerability factors for the development of internalizing disorders (e.g., Beck, 1979; Hollon, Stewart & Strunk, 2006). Men and women with sexual dysfunction also have been found to have more negative sexual schemas (i.e., deep, persistent beliefs about sex) than people without sexual dysfunction (Nobre & Pinto-Gouveia, 2009; Peixoto & Nobre, 2015). These maladaptive schemas, such as failure expectancies, incompetence self-schemas, perceived lack of control, and hyper-vigilance (Nobre, 2009; Nobre & Pinto-Gouveia, 2008a, 2009; Oliveira & Nobre, 2013a; Peixoto & Nobre, 2014; Quinta Gomes & Nobre, 2012; Wiegel, Scepkowski & Barlow, 2007) are also characteristic of internalizing disorders (Pinto-Gouveia, Castilho, Galhardo & Cunha, 2006; Schmidt, Joiner, Young & Telch, 1995; Young, Klosko & Weishaar, 2003). Perhaps as a consequence of these negative schemas, people with a sexual dysfunction have been found to endorse cognitive distortions (Rosen, Leiblum & Spector, 1994), and report negative automatic thoughts (Nobre & Pinto-Gouveia, 2008c) that are associated with impaired arousal and orgasmic function in particular (Nobre & Pinto-Gouveia, 2008a, 2008b).

Additional parallels between cognitive and emotional processing in low sexual function and internalizing disorders are evident in the context of Barlow et al.’s (2010) recent cognitive model of internalizing psychopathology where aversive reactions to negative emotions lead to attempts to control, avoid, or suppress these emotions (e.g., situational, cognitive, and behavioral avoidance; Brown & Barlow, 2009), which ultimately fail and maintain the cycle of distress (Barlow et al., 2010). Behavioral and cognitive avoidance are also evident in sexual dysfunctions; for example, behavioral intimacy avoidance is often characteristic of chronic low sexual function (Lewis et al., 2010). Cognitive avoidance is also central to the disruption of sexual response, where cognitive biases orient towards the threat in erotic cues, triggering negative automatic thoughts and cognitive distraction and avoidance (Carvalho & Nobre, 2011a; Cuntim & Nobre, 2011; Peixoto & Nobre, 2012; Strub, 2013). This effect is particularly potent for impaired male sexual desire (Carvalho & Nobre, 2011b), male and female subjective arousal (Nobre & Pinto-Gouveia, 2008a; Oliveira et al., 2014), and female orgasm (Cuntim & Nobre, 2011). These maladaptive cognitive processes have been found to act for men and women of different sexual orientations (e.g., Peixoto & Nobre, 2014, 2015), in a variety of cultures (Abdolmanafi et al., 2015; Beard & Amir, 2010; Dosch et al., 2016; Sbrocco & Barlow, 1996; van den Hout & Barlow, 2000; Weisberg, Brown, Wincze & Barlow, 2001), and operate independently from the effect of co-occurring symptoms of depression and anxiety (Carvalho & Nobre, 2011a; Oliveira & Nobre, 2013a; Quinta Gomes & Nobre, 2012).

Temperamental antecedents

Internalizing disorders and sexual dysfunctions also have overlap in their associated personality and emotional traits. For example, high levels of neuroticism appear to confer a risk for internalizing psychopathology, in line with their conceptual overlap (Krueger & Markon, 2006); and people presenting with sexual dysfunctions have been found to have high levels of neuroticism, even after controlling for other psychopathology (Harris, Cherkas, Kato, Heiman & Spector, 2008; Quinta Gomes & Nobre, 2011; Watts & Nettle, 2010). Neuroticism scores on the NEO-Five Factor Inventory have also been found to predict the overall frequency of negative sexual cognitions (Moyano & Sierra, 2013). More broadly, sexual dysfunctions share the high level of negative affect that characterizes internalizing disorders, which is a general dimension of fear, anger, sadness, guilt, worry, and disgust (Clark & Watson, 1991); high levels of these emotions are related broadly to low sexual function (Oliveira & Nobre, 2013b; Peixoto & Nobre, 2012), and specifically to lower sexual arousal (Nobre & Pinto-Gouveia, 2008a; Oliveira et al., 2014; Peixoto & Nobre, 2012; Vilarinho et al., 2014) and sexual desire (Carvalho & Nobre, 2011b; Nobre & Pinto-Gouveia, 2008b) in men and women. Consistent with this, men and women with sexual dysfunctions report higher levels of negative affect —particularly during sexual activity— compared to people without sexual dysfunctions (Nobre & Pinto-Gouveia, 2006b; Peixoto & Nobre, 2016), and sexual dysfunctions are also generally related to both temporary and recurrent negative affect (Wiegel et al., 2007).

Treatment response

These shared cognitive and affective processes are possible reasons for the response of sexual dysfunctions to treatments shared with internalizing disorders (Strub, 2013). For example, female sexual desire, arousal, orgasm, and sexual pain disorders; as well as male premature ejaculation, erectile dysfunction, and delayed ejaculation have been found to respond to cognitive-behavioral and mindfulness therapies (Andersson et al., 2011; Brotto, Basson & Luria, 2008; Brotto, Basson, Smith, Driscoll & Sadownik, 2015; Brotto & Smith, 2014; Brotto, Woo & Leiblum, 2010; Frühauf, Gerger, Schmidt, Munder & Barth, 2013; Jones & McCabe, 2011; Mohammadi, Mohammadkhani, Dolatshahi & Dadkhah, 2013). This is not conclusive evidence, as cognitive-behavioral therapy (CBT) covers a broad variety of therapeutic techniques that can be effective for most mental disorders. However, the fact that these same techniques have been applied to treat sexual dysfunctions, with similar effects (e.g., McCabe, 2001; Trudel et al., 2001), is consistent with shared treatment response between the disorders.

Stronger evidence for shared treatment response between the disorders is found in experimental studies that have shown that sexual response can be manipulated by altering schemas and moods (Kuffel & Heiman, 2006; ter Kuile, Both & Van Uden, 2010), which are specifically targeted in CBT for internalizing disorders (e.g., Allen et al., 2008; Barlow et al., 2010; Boisseau, Farchione, Fairholme, Ellard & Barlow, 2010). These studies offer preliminary evidence for specific shared mechanisms and processes that may foster comorbidity between the disorders, which is a necessary step before it is possible to develop and test interventions to prevent their comorbidity (Kessler & Price, 1993).

Finally, there is additional evidence for shared treatment response in studies that have found sexual function to improve with treatment for internalizing disorders (e.g., Hoyer, Uhmann, Rambow & Jacobi, 2009; Schnurr et al., 2009; ter Kuile, Both & van Lankveld, 2010), and in studies that have found internalizing disorders to improve with treatment for sexual dysfunctions (e.g., Bocchio et al., 2009; Chudakov, Matar & Kaplan, 2008).

The effect of selective serotonin reuptake inhibitors (SSRIs) is a notable exception to this pattern of shared treatment response: SSRIs are the most widely prescribed class of antidepressant medication used to treat depressive and anxiety disorders in many countries, such as the United States (e.g., Preskorn, Ross, & Stanga, 2004), but are associated with a high risk for antidepressant-induced sexual dysfunction (Keks, Hope & Culhane, 2014; Balon, 2006b). The precise mechanisms underlying this relationship are not known. One specific mechanism that may account for antidepressant-induced sexual dysfunction is the SSRI activation of the 5-HT2 receptor, which impairs all stages of sexual response for men and women (Zemishlany & Weizman, 2008). More broadly, the sexual dysfunction side effects of SSRIs are likely due to a combination of their effects on serotonergic tone, reduction in dopaminergic activity and reuptake, reduction in noradrenergic transmission, and reduction in nitric oxide levels (e.g., Bredt et al., 1991; Schatzberg, Cole & DeBattista, 2007; Schatzberg & Nemeroff, 2009); these neurotransmitter systems are involved in both sexual dysfunctions and internalizing disorders, as discussed below. Interestingly, given serotonergic tone predicts ejaculatory latency (in animal models; Waldinger, 2002), SSRIs have been found to be an effective treatment for premature ejaculation (e.g., Giuliano & Hellstrom, 2008).

Neural substrates

Given the complexity of the relationships between neurobiological mechanisms that interact to allow for positive sexual function (e.g., Clayton, 2007; Yehuda, Lehrner & Rosenbaum, 2015), this area of the literature is largely beyond the scope of our review. Briefly, many of the brain systems that are involved in internalizing disorders have also been found to have a role in sexual response. For example, activation of the hypothalamic-pituitary-adrenal axis and amygdala may interfere with sexual function (Baird, Wilson, Bladin, Saling & Reutens, 2007; Hamilton & Julian, 2014). Further, high levels of the hormone cortisol are associated with lower subjective desire and arousal in women, where high cortisol may predispose women to have a negative assessment of sexual stimuli (Dundon, 2014).

In particular, there is substantial overlap in the neurotransmitter systems that have a role in internalizing disorders and sexual response. As mentioned above, dopaminergic, noradrenergic, and serotonergic neurotransmitter systems are involved in sexual dysfunction: Desire and arousal function are increased by disinhibition of dopaminergic systems (Meston & Frohlich, 2000; Bancroft & Janssen, 2000). Noradrenergic neurophysiology is also related to male erection and ejaculations, and may explain the link between anxiety and spontaneous ejaculation (Redmond, Kosten & Reiser, 1983; Segraves, 1989). The role of serotonergic neurotransmission is more complex, with serotonin likely modulating both excitatory and inhibitory pathways for sexual behavior (e.g., Bancroft & Janssen, 2000), and generally thought to impede sexual function (Frohlich & Meston, 2000; Miner & Seftel, 2007; Segraves, 1989). An early formulation of the monoamine theory of depression postulated that the effectiveness of antidepressant agents owed to a fundamental deficit of neurotransmitters (primarily serotonin and noradrenaline) in individuals with depression (see Hirschfield, 2000). This deficit was thought to be corrected by blocking transporters that would normally remove serotonin from the synaptic cleft. Recent research, however, now attributes the effectiveness of serotonergic antidepressants to downstream effects that increase synaptogenesis and neurogenesis by modulating neuronal growth factors (e.g. brain-derived neurotrophic factor; Lee & Kim, 2010). Thus, the monoamine hypothesis of depression is likely misguided, and the apparent contradiction in increased serotonin impeding sexual function but alleviating depression is unlikely to hold.

In short, all of the neural substrates mentioned here have a prominent role in internalizing disorders as well as sexual function (Goldberg, Krueger, Andrews & Hobbs, 2009; Hirschfeld, 2000; Levine, 2000; Pariante & Lightman; Stein, Westenberg & Liebowitz, 2002; Vaidyanathan, Patrick & Cuthbert, 2009; Vreeburg et al., 2010). As such, it seems likely that there are shared substrates between internalizing disorders and low sexual function.

Biomarkers

Studies that have examined biomarkers like cardiovascular reactivity, galvanic skin response, and vaginal pulse amplitude have found commonalities among the physiological responses that characterize anxiety and low sexual function. In particular, the sympathetic nervous system (SNS) has a prominent role in sexual function that is similar to its role in internalizing disorders (Hoehn-Saric & McLeod, 1988; Veith et al., 1994; Villacres, Hollifield, Katon, Wilkinson & Veith, 1987). For example, high and low levels of SNS activation are associated with impaired desire, arousal, and orgasm (Corretti & Baldi, 2007; Lorenz, Harte & Meston, 2015), but moderate levels of SNS activation may facilitate physiological sexual arousal in particular (Lorenz et al., 2015; Meston, 2000; Meston & Gorzalka, 1996). This inverted U-shaped relationship appears to be limited to healthy and sexually functional people who mislabel their physiological arousal as sexual arousal (i.e., excitation transfer; Elliot & O’Donohue, 1997; Palace & Gorzalka, 1990; van den Hout & Barlow, 2000).

In contrast, SNS activation appears to have a positive linear relationship with disrupted sexual response in people with existing sexual difficulties, and people with higher levels of anxiety, who are more likely to focus attention selectively on non-erotic and/or threatening cues, which increases anxiety and impairs subjective and physiological arousal (van den Hout & Barlow, 2000; van Minnen & Kampman, 2000). Correspondingly, many of the same experimental studies that have examined the impact of SNS activation and state anxiety have found distraction (i.e., a shared cognitive component of state and trait anxiety) to have a negative impact on sexual arousal for sexually functional and dysfunctional participants, as it increases the salience of non-erotic cues, preventing positive cognitive and emotional feedback and subsequent subjective arousal (Basson, 2002; Corretti & Baldi, 2007; Corretti et al., 2006; Elliot & O’Donohue, 1997).

Another shared biomarker is low resting heart rate variability —a measure of autonomic nervous system (ANS) activity— which is a marker of depression and anxiety (Kemp, Quintana, Felmingham, Matthews, & Jelink, 2012; Kemp, Quintana, Gray, Felmingham, Brown, & Gatt, 2010), and has recently been found to predict female sexual arousal and orgasmic function (Costa & Brody, 2012; Stanton, Lorenz, Pulverman & Meston, 2015) and erectile dysfunction (Lee, Joo, Kim, Cho, Cho, Won & Choi, 2011). Serum markers of inflammation that are associated with depression (e.g., Ramsey et al., 2016) have also been found to predict erectile dysfunction (e.g., Vlachopoulos et al., 2006). Taken together, these findings suggest there are shared biomarkers for internalizing psychopathology and low sexual function.

Disorder course

Lastly, the course of internalizing disorders and sexual dysfunctions is similar. For example, the latent internalizing spectrum —as a statistical representation of the level of risk for developing an internalizing disorder— is stable over time (Eaton, Krueger & Oltmanns, 2011; Krueger, 1999; Sunderland, Slade, Carragher, Batterham & Buchan, 2013; Vollebergh et al., 2001). In other words, although individual disorders may remit and recur over time, the underlying liability for disorders to develop as manifestations of the internalizing spectrum remains relatively stable (Eaton et al., 2011). This course of internalizing psychopathology as a whole is consistent with the course of individual depressive and anxiety disorders, as well as sexual dysfunctions, which tend to be persistent with high rates of recurrence and are often chronic across the lifespan (APA, 2013).

Conflicting evidence

There is one consistent finding that stands in contrast to the studies reviewed above: Three studies have found that some men and women experiencing depressive symptoms report elevated desire (Bancroft et al., 2003a; Frohlich & Meston, 2002; Nofzinger et al., 1993). Nofzinger et al. (1993) found that this relationship was specific to episodes of atypical depression, and was not evident in anhedonic, endogenous, or melancholic depression. It seems likely that these studies may be describing the same phenomenon, as Frohlich and Meston (2002) and Bancroft et al. (2003a) did not test for features of atypical depression, which can manifest as mild symptoms of major depression on self-report inventories (e.g., Fabre & Smith, 2012). A specific relationship between atypical depression and elevated desire would also be consistent with the finding that atypical depression is associated with lower rates of sexual dysfunction than major depression in men and women (Fabre, Clayton, Smith, Goldstein & Derogatis, 2013; Fabre & Smith, 2012), and could be explained by the mood reactivity to potential positive events in atypical depression, which may reinforce sexual approach behaviors. In contrast, in other types of depression, the ongoing dysphoria and anhedonia may disrupt the process by which pleasurable behaviors are reinforced (Frohlich & Meston, 2002). Either way, these findings are important to consider, as they highlight the importance of nuanced analyses that do not presume the same interrelationships in all groups (e.g., factor mixture analyses, which are explored in more detail in Part 3).

Integrating the substantive evidence

There are gaps in the research, particularly regarding the validators related to shared risk factors (i.e., genetic, familial, and environmental risk factors), which require epidemiological twin studies that assesses common mental disorders and sexual function at the same time. However, there is evidence from multiple streams of research that highlight robust multifaceted relationships between the established core internalizing disorders and low sexual function. If we discount the possibility that these relationships occur by chance, there are three types of relationships that could account for these findings: 1) internalizing disorders cause sexual dysfunctions, 2) sexual dysfunctions cause internalizing disorders, and/or 3) internalizing disorders and sexual dysfunctions share a set of common causes, which can be summarized by the internalizing spectrum. In fact, all three of these statements can hold simultaneously. The only way to adjudicate which hypothesis best accounts for the robust multifaceted relationships is to analyse longitudinal data: Prominent unidirectional relationships between internalizing psychopathology and sexual function—in either direction—would support the former two hypotheses; systematic bidirectional relationships would be consistent with either a shared set of common causes or reciprocal causality accounting for their overlap; and an absence of directional relationships would suggest that a shared set of common causes accounts for their overlap. Longitudinal research to date has consistently found small bidirectional relationships or no directional relationships between these constructs (Atlantis & Sullivan, 2012; Forbes et al., 2015a; Kalmbach, Pillai, Kingsberg & Ciesla, 2015; Peleg-Sagy & Shahar, 2013), in line with the internalizing hypothesis, but no longitudinal study to date has found evidence for substantial unidirectional or bidirectional relationships to the best of our knowledge. Many researchers have correspondingly proposed that internalizing symptoms and low sexual function may be manifestations of the same underlying processes (Atlantis & Sullivan, 2012; Corretti et al., 2006; Kalmbach et al., 2015; Oliveira & Nobre, 2013b; Peixoto & Nobre, 2012; van Lankveld & Grotjohann, 2000; Watts & Nettle, 2010). In short, the multifaceted relationships between the disorders combined with the lack of any evident unidirectional causal relationships suggest that conceptualizing sexual dysfunctions as manifestations of the internalizing spectrum is both a plausible and parsimonious explanation for these patterns of associations.

We note again that we are not proposing the internalizing spectrum is the only —or even the most influential— determinant of low sexual function. Krueger (1999) found that the internalizing spectrum accounted for 32–58% of the variance in the internalizing disorders, and Eaton et al. (2013) found that the lower-order fear and distress spectra accounted for 48–80% of the variance in the internalizing disorders. There is evidence for a similar relationship between internalizing and low sexual function: Forbes et al. (2015a) found that 28–80% of the variance in most domains of male and female sexual function was accounted for by a longitudinal internalizing spectrum model5. This means that in our proposed model, an average of a fifth to two-thirds of the variance in sexual function would still be attributable to other factors, such as biological and medical vulnerabilities (e.g., hormone levels, diabetes), social context (e.g., poor communication, relationship problems, sex-roles, religious ideas) and environmental factors (e.g., lack of privacy, pets, work schedules; Wincze & Weisberg, 2015). Further, the amount of variance accounted for by the internalizing spectrum —and other determinants of low sexual function— would vary from person to person such that for some individuals low sexual response might only be an adaptive reaction to their social context, or due to a medical condition, for example.

In summary, the extant literature offers robust evidence consistent with the hypothesis that the internalizing spectrum is a core underlying vulnerability for sexual dysfunctions. There are eight studies that have been published in the last five years that provide direct support for this hypothesis. We will now turn to review these studies.

Part 3: Studies that have tested the hypothesis that sexual problems are part of the internalizing spectrum

In their review, Laurent and Simons (2009) proposed that sexual dysfunctions may form part of the internalizing spectrum, and that specific types of low sexual function might have differential relationships with narrower facets of internalizing. Specifically, they suggested that low sexual function related to physiological arousal (e.g., erectile function, lubrication, and sexual pain) could be differentially related to anxiety disorders —that is, with the fear sub-factor of internalizing in Krueger’s (1999) model or the anxious arousal factor in Clark and Watson’s (1991) tripartite model. Similarly, they suggested that low sexual function with more prominent cognitive, motivational, and pleasure-seeking components (e.g., low desire and orgasmic function) might be related to the distress sub-factor of internalizing in Krueger’s model or the anhedonia factor in Clark and Watson’s model.

This set of hypotheses has largely been tested in the context of Clark and Watson’s (1991) tripartite model. For example, Kalmbach and colleagues have examined these hypotheses for self-reported female sexual function —mostly in young women— in daily diary studies (Kalmbach, Kingsberg & Ciesla, 2014; Kalmbach & Pillai, 2014), a large cross-sectional study (Kalmbach, Ciesla, Janata & Kingsberg, 2012), and a prospective longitudinal study over five weekly assessments (Kalmbach et al., 2015). Their regression analyses across the four studies converged on largely consistent patterns of findings. Kalmbach et al. focused on the unique relationships of the three domains in the tripartite model with different domains of sexual function, and found that anhedonia was consistently uniquely related to low levels of desire. Anxious arousal also had consistent relationships with difficulties with lubrication and pain (Kalmbach et al., 2012; Kalmbach et al., 2014; Kalmbach & Pillai, 2014); and negative affect was uniquely related to more difficulties with orgasm in the daily diary studies (Kalmbach et al., 2014; Kalmbach & Pillai, 2014). These findings are broadly consistent with Laurent and Simons’ (2009) hypotheses, but it is important to note that they relate only to female sexual function over brief time periods, and are limited by the predominance of women under 45 in the samples. Forbes and Schniering (2013) also tested these hypotheses—using a more diverse sample of men and women—in the context of Krueger’s (1999) internalizing spectrum model. Forbes and Schiering found that the specific relationships hypothesized by Laurent and Simons (2009) were not needed to explain the data; instead, a higher-order internalizing dimension accounted for the shared variance between the disorders to the extent that the specific cross-loadings to fear and distress did not account for any additional variance. It would be interesting for future research to test the fit of a model that does not include a low sexual function latent variable, but treats sexual function domains as direct indicators for the fear and distress spectra.

While Kalmbach and colleagues’ studies focused on the unique relationships between anhedonia, anxious arousal, and negative affect with specific domains of sexual response, the internalizing spectrum lies in the shared variance between these factors (i.e., the overlap between them), as well as in their unique components. As such, in these studies it is the predictive validity of the model as a whole that tests whether sexual function is related to internalizing. Although it is not highlighted in Kalmbach and colleagues’ papers, it is noteworthy then that they found the combination of the three factors together were consistently associated with lower levels of female sexual desire, subjective and physiological arousal, and orgasm function, and higher levels of pain (Kalmbach et al., 2012; Kalmbach et al., 2014; Kalmbach & Pillai, 2014; Kalmbach et al., 2015). This was the case when examining state (Kalmbach et al., 2015) and trait (Kalmbach et al., 2012) affect, as well as symptoms of anxiety and depression specifically (Kalmbach et al., 2014). In short, these four studies all converge on evidence for multivariate relationships among these constructs for women. In additional support for the sexual problems forming part of the internalizing spectrum, Kalmbach et al. found that these multivariate relationships were almost exclusively concurrent, and did not find any consistent time-lagged relationships between studies, which suggests that there were no evident causal relationships on a daily (Kalmbach et al., 2014; Kalmbach & Pillai, 2014) or weekly (Kalmbach et al., 2015) time scale. While Kalmbach and colleagues’ work was largely focused on female sexual function, Kalmbach et al. (2012) also included young men, and found that subjective arousal, erectile function, and orgasmic function were all predicted by the internalizing domains, but desire was not. This aberration is noteworthy in the context of the studies reviewed below, and will be revisited later.

The strongest evidence supporting the hypothesis that sexual problems are part of the internalizing spectrum comes from the work by Forbes and colleagues (Forbes et al., 2015a, 2015b, 2016; Forbes & Schniering, 2013), which specifically tested this hypothesis in the context of Krueger’s (1999) internalizing spectrum model for men and women across four studies. These studies included cross-sectional (Forbes et al., 2015b, 2016; Forbes & Schniering, 2013) and longitudinal (Forbes et al., 2015a) data and utilized a variety of self-report measures (Forbes et al., 2015b; Forbes & Schniering, 2013), different inclusion criteria (i.e., penetrative sexual intercourse in the past four weeks in Forbes et al., 2016; sexual activity including masturbation in the past four weeks Forbes & Schniering, 2013; and no specific requirements regarding sexual activity in Forbes et al., 2015a, 2015b), and statistical modeling methods with divergent assumptions and limitations across all four studies. This heterogeneity in the methods between the studies is important because it strengthens our confidence in the findings of the body of research as a whole. Forbes and colleagues measured self-reported symptoms of common internalizing disorders (e.g., depression, GAD, social anxiety, panic and agoraphobia, OCD) as well as domains of sexual function (e.g., desire, arousal sensation, cognitive arousal, lubrication, orgasm function, sexual pain, and sexually related distress for women; desire, erectile function, ejaculatory control and related distress, and sexual satisfaction for men; e.g., Forbes et al., 2015b; Forbes & Schniering, 2013) and focused on finding the best statistical model to describe the relationships between these domains. These studies relied on convenience samples from the community (i.e., tending to be young and well-educated), which limits their generalisability (Laumann, Paik, & Rosen, 1999; Lutfey et al., 2009), but they do represent diverse symptom levels similar to or higher than population norms for most symptom measures, including 20–40% of the primary samples reaching clinical cut-offs for moderate or severe impairment for most disorders in Forbes et al. (2015a, 2015b). We introduce these studies individually below, before integrating their findings for men and women in the context of the literature.

Forbes and Schniering (2013) used structural equation modeling (SEM) as the first test of an expanded dimensional model of the internalizing spectrum that included sexual problems alongside symptoms of depression, GAD, social anxiety, panic disorder, and agoraphobia (cf. Figure 2). This model was tested separately for men and women; it provided comparatively better fit than models based on Laurent and Simons’ (2009) specific hypotheses described above, as well as models based on the DSM-IV that conceptualized sexual problems as unrelated to depressive and anxiety disorders. However, while the internalizing model provided excellent absolute fit to the data for women, it did not have strong model fit for men. Forbes and Schniering (2013) attributed this to the narrow range of sexual problems in the male sample.

An external file that holds a picture, illustration, etc. Object name is nihms854523f2.jpg
Figure 2

An example of a model of the Internalizing spectrum that includes female sexual problems, reflecting the findings of Forbes and Schniering (2013) and Forbes et al. (2015a, 2015b, 2016). MDD = major depressive disorder; GAD = generalized anxiety disorder; FSIAD = female sexual interest/arousal disorder; FSOD = female sexual orgasm disorder; PPD = genito-pelvic pain/penetration disorder. As for Figure 1, the rectangles represent observed variables (e.g., DSM diagnoses rated as present or absent), which act as indicators for the latent variables (i.e., the ellipses). Each latent variable represents the shared variance among its indicator variables, and these relationships are represented by the single-headed arrows. Double-headed arrows represent correlations between variables.

Forbes et al. (2016) subsequently compared latent profile analyses (LPA) of the data with SEM in the same sample. The aim of this study was to explicitly compare the dimensional internalizing model in Forbes and Schniering (2013) to a categorical model of the relationships. In LPA, individuals are grouped by shared symptom profiles. If the profiles are qualitatively distinct (e.g., characterized by specific groups of symptoms or disorders), this suggests that the disorders belong to different diagnostic categories. Alternatively, if the profiles are parallel, this suggests the groups only differ on symptom severity, which is consistent with an underlying dimensional spectrum between the disorders. Forbes at al. (2016) found that the dimensional internalizing (SEM) model fit better —for men and for women— than the categorical LPA models, and the strongest LPA models had largely parallel profiles. Interestingly, while the overwhelming majority of men and women in the sample (96% and 100%, respectively) had strong dimensional relationships consistent with the internalizing spectrum (i.e., depressive and anxiety disorders systematically covaried with low sexual function), symptoms of depressive and anxiety disorders were unrelated to low sexual function for 4% of men. Given these men reported particularly low erectile function, one explanation for this finding may be that they were experiencing primarily organic —rather than psychogenic— erectile dysfunction (i.e., due to substance or medication use, or due to a medical condition; cf. APA, 2013).

In a larger convenience sample, Forbes et al. (2015b) examined factor mixture analyses of the relationships between depressive and anxiety symptoms and low sexual function. This type of analysis allows for a model to have categorical and dimensional components simultaneously. For example, within a single factor mixture analysis participants’ responses can be split into groups with different structural relationships so that one group can have strong dimensional relationships between internalizing symptoms and low sexual function, while for another group these domains are unrelated. Factor mixture analyses can thus detect common processes for large groups of people, but also allow for different structural relationships within groups that do not share these common processes. This feature is excellent for modeling psychological processes involved in sexual function, as we know that not all experiences of low sexual function will be related to internalizing psychopathology. The findings of Forbes et al. (2015b) reaffirmed the dimensional internalizing structure for all of the women, and found even stronger dimensional relationships for 87% of the men. Interestingly, 13% of men had categorical distinctions between sexual function and symptoms of depressive and anxiety disorders, mirroring the smaller group of men with categorical distinctions in Forbes et al. (2016). We will revisit these findings later.

Finally, Forbes et al. (2015a) used SEM to examine the longitudinal relationships between the disorder constructs at a latent level. An internalizing structure fit best, and was invariant over the course of four weeks for men6, and over the course of one week, four weeks, and six months for women. There were no evident causal relationships (i.e., cross-lags) in any of these models, which supports the hypothesis of a shared underlying factor accounting for change in the disorders over time, as discussed in Part 2. Taken together with Kalmbach et al.’s (2015) longitudinal study, there is evidence for concurrent change in depression, anxiety, and women’s self-reported low sexual function in a variety of time scales, ranging from one day to six months.

Results for women

Overall, the results for women were consistent within and between the eight studies, which all showed dimensional relationships between low sexual function and internalizing psychopathology in community samples. These relationships were evident in women who were sexually active with a partner (Forbes et al., 2016; Forbes & Schniering, 2013) as well as those who were not (Forbes et al., 2015a, 2015b). While Kalmbach et al. (2014a, 2014b, 2012) found desire, arousal, orgasm, and pain to be consistently related to symptoms of depression and anxiety, Forbes and colleagues had some variability in the findings for specific disorders across the studies. For example, initial findings suggested that female sexual desire was weakly associated with the internalizing spectrum (Forbes & Schniering, 2013), and it was subsequently excluded in the next analysis of that sample (Forbes et al., 2016). Forbes and Schniering (2013) hypothesized that this finding was due to the poor measurement of desire in the Female Sexual Function Index (cf. Forbes, Baillie & Schniering, 2014; Rosen et al., 2000). Consistent with this, when the Abbreviated Sexual Function Questionnaire (Williams, Abraham & Symonds, 2010) was used, desire was a strong indicator for the models (Forbes et al., 2015a, 2015b). On balance, these later results —in combination with Kalmbach et al.’s four studies and with the larger literature that has found depression and anxiety to be related to low levels of desire (e.g., see Laurent & Simons, 2009 for a review)— suggest that desire is a good indicator of the internalizing spectrum.

Forbes et al. (2015a, 2015b) also found that sexual pain and sexually-related distress were more closely related to depressive and anxiety disorders than to other domains of female sexual function, which means that a model based on Figure 2 may not be an ideal representation of these specific relationships (i.e., where pain and distress are only related to depressive and anxiety disorders via their relationship to the latent sexual function variable). This finding for pain is consistent with research that has found pain to operate independently of other domains of sexual function (e.g., Binik et al., 2002) but to be closely related to depression and anxiety (e.g., Kaya et al., 2006). Similarly, the result for distress is consistent with Bancroft et al.’s (2003b) finding that emotional wellbeing —rather than sexual function specifically— is the best predictor of distress. Future studies could examine these relationships in an exploratory SEM framework to allow for more flexibility in the relationships among the disorders. Overall, the studies based on female samples depict a complex set of interrelationships that are consistent with the body of research reviewed in Part 2, and uniformly show clear dimensional relationships between internalizing disorders and low sexual function.

Results for men

After accounting for the small groups of men that apparently had non-psychogenic low sexual function, 87–96% of the men in Forbes et al. (2015b, 2016) had strong dimensional relationships between depressive and anxiety disorders and low sexual function, consistent with a shared internalizing spectrum. In fact, these dimensional relationships were even stronger than those found for women. Overall, self-reported erectile function, premature ejaculation, and sexual satisfaction (included to operationalize low sexually-related distress) were consistently related to symptoms of depression and anxiety (Forbes et al., 2015a, 2015b, 2016; Forbes & Schniering, 2013; Kalmbach et al., 2012). While the generalisability of these studies is limited by the non-representative samples —particularly by the young male samples in Forbes and Schniering (2013), Forbes et al. (2016), and Kalmbach et al. (2012)— Forbes et al. (2015a, 2015b) had better measurement and more diversity in symptom levels, and these latter studies found the strongest evidence for dimensional relationships for men.

One consistent and puzzling finding was that male sexual desire was a poor indicator of the internalizing spectrum in every study (Forbes et al., 2015a, 2015b, 2016; Forbes & Schniering, 2013; Kalmbach et al., 2012) despite their divergent statistical approaches, and the use of three different self-report measures. As such, it is unlikely that this finding was due solely to poor measurement (cf. Forbes, 2014; Forbes et al., 2014; Forbes et al., 2016). An alternative explanation could be that none of the studies differentiated between dyadic and solitary desire. Spector, Carey, and Steinberg (1996) suggested that solitary desire might serve a different purpose (e.g., tension release) than the emotional and physical intimacy associated with dyadic desire. Thus, we may expect dyadic desire to covary with internalizing symptoms, but solitary desire may play more of a self-soothing role, and be heightened during negative mood states (Frohlich & Meston, 2002). Alternatively, there may have been insufficient variability in sexual desire (i.e., restriction of range) in the samples, given all of the studies relied predominantly on young, healthy, and educated men from the community. The relationship between low sexual desire and depression in particular has been documented to the extent that a decrease in libido “is an indicator of depression in all patient cohorts except in women older than 70 years” (Baldwin, 1996, p. 31), so it is likely that clinical samples and/or higher symptom levels may be required to identify this relationship.

Integrating the findings of the eight studies

Taken together, the eight studies that have analyzed the overarching relationships between the disorders are consistent with the hypothesis that low sexual function shares a common underlying factor of internalizing psychopathology with depressive and anxiety disorders for men and women. The relationships in Forbes et al.’s (2013, 2015a, 2015b, 2016) models showed that anxiety and depressive symptoms were more strongly related to each other than they were to low sexual function. However, this was expected, and is likely due to the variety of etiologic factors that influence sexual function —as discussed earlier— as well as the shared symptoms between depressive and anxiety disorders, the overlap in the domains that are measured (i.e., cognitive and emotional versus sexual), and the similar stem-and-response measures for depressive and anxiety symptoms (i.e., measurement overlap). The strongest case for interpreting these studies’ findings as an indication of a shared liability between the disorders is in their high rates of comorbidity; shared cognitive, affective, and personality characteristics; common neural substrates and biomarkers; shared course and treatment response; and the lack of unidirectional causal relationships between them.

On the whole, there are fewer gender differences in the studies than we might have expected based on a review of the body of research on male and female sexual response cycles. For example, a simple linear sexual response cycle is generally accepted for men (Masters & Johnson, 1970). However, this model has been challenged for women, where motivation to engage in sexual activity and other contextual factors are given a prominent role, and desire and arousal are particularly intertwined with one another (Basson, 2000, 2001, 2005; Brotto, Graham, Binik, Segraves & Zucker, 2010). In contrast, within the literature more broadly, the results of some factor analytic studies suggest that there may in fact be similarities between men and women who experience low sexual function, and between men and women who do not. The sexual response cycle has been found to have distinct desire, arousal, and orgasm phases for men and women without low sexual function (Carvalho, Vieria & Nobre, 2011; Giles & McCabe, 2009), whereas sexual desire, arousal, and orgasm tend to overlap for men and women experiencing low sexual function (Carvalho, Vieira & Nobre, 2012; Carvalho et al., 2011; Corona et al., 2015; Giles & McCabe, 2009). These findings are consistent with the notion of higher symptom severity being associated with greater comorbidity (Kessler et al., 2005; Krueger, 1999), and with the similar dimensional findings for men and women across Forbes et al.’s (2015a, 2015b) later studies in particular.

Overall, these eight studies examined the relationships among depressive and anxiety symptoms and low sexual function in five different statistical frameworks. However, it is important to note that while the studies’ findings are all consistent with the internalizing hypothesis, they are by no means conclusive. For example, as we discussed in Part 2, the robust multifaceted relationships among the constructs could be accounted for by a variety of theoretical models, including causal relationships between internalizing disorders and sexual dysfunctions. Forbes et al. (2015a) is the only study to have tested the extended internalizing model using longitudinal data, and found no evidence for unidirectional causal relationships, in line with existing longitudinal studies of the relationships among internalizing symptoms and sexual function (e.g., Atlantis & Sullivan, 2012; Peleg-Sagy & Shahar, 2013). As such, the extant literature is more closely aligned with a shared common causes model (i.e., including sexual dysfunctions in the internalizing spectrum), rather than causal relationships accounting for their interrelationships.

To solidify the grounding of this hypothesis, the potential for unidirectional causal relationships should also be examined on shorter and longer time scales. For example, causal relationships could exist on a momentary time scale where emotional stress causes difficulties in becoming aroused, or on a larger time scale where years of chronic sexual dysfunction eventually foster depression or anxiety. The net effects of these time scales are included in extant research, but in order to disentangle the relationships, these models should be examined using data from ecological momentary assessment and longitudinal epidemiological research, respectively. Future research on these questions need not use a SEM framework, but could also use mixed models, longitudinal panel modeling, or factor mixture models (i.e., to allow for groups with different structural relationships; cf. Forbes et al., 2015b), and should focus on elucidating these relationships for men in particular.

As we have alluded to throughout Part 3, these eight studies are also limited by their reliance on convenience samples of predominantly young, educated, and healthy participants, as well as their reliance on self-reported measurement of the constructs of interest. The use of non-clinical samples means that low sexual function was not necessarily accompanied by the clinically significant distress that is needed to make a diagnosis of a sexual dysfunction, and may have been an adaptive response to other factors (e.g., social or environmental context) for some individuals. However, the use of non-clinical samples is also a strength: To date, there has been very little research on these disorders in non-clinical samples, as most studies begin with a base population of participants with diagnosed sexual dysfunctions or depressive or anxiety disorders (Laurent & Simons, 2009). Research that relies on clinical samples is vulnerable to Berkson’s bias (Berkson, 1946), which states that comorbid cases are more common in clinical samples than the population at large, even if the probability of seeking help is independent of disorder severity. These high comorbidity rates are associated with elevated distress, and, importantly, with restricted range in symptom variation due to the nature of the exclusively high-symptom sample (see Edwards, 1976). The inclusion of a broad range of symptom levels (e.g., Forbes et al., 2015a, 2015b) is vital to understand the nature of the relationships that describe the covariation among disorders, so an investigation of these relationships in diverse non-clinical samples provides particularly useful information. The dimensional structure of psychopathology has been found to have high levels of similarity between clinical and non-clinical samples (O’Connor, 2002). As such, the extension of the internalizing spectrum in a sample of participants across a variety of symptom levels offers important insights into the relationships between the disorders, and is relevant to both epidemiological and clinical research.

Another limitation of these eight studies was that while they examined the most common experiences of low sexual function (McCabe et al., 2016), and the five of seven core common internalizing disorders (e.g., Krueger, 1999; Krueger et al., 1998), they did not measure delayed ejaculation, and could not provide divergent evidence that sexual problems are part of the internalizing spectrum specifically, as opposed to, say, the externalizing or thought disorders spectra. As such, future research should include clinical samples and epidemiological samples, as well as broader measurement of psychopathology and sexual function.

In short, the eight studies that have tested whether low sexual function might be an indicator of the internalizing spectrum have found empirical support for this model. These studies, together with the literature reviewed in Part 2, thus provide robust evidence that sexual dysfunctions have a clear place in the meta-structure of psychopathology as part of the internalizing spectrum, and this has important implications for research and practice, as discussed below. The findings of these studies also highlight that the DSM —and the International Classification of Diseases (World Health Organization, 2008) do not accurately represent the interrelationships between the disorders. Accurate models of these relationships are important precursors for the development of an empirically based nosology, sensitive diagnostic protocol, and efficacious treatment programs. As such, the internalizing spectrum —as part of the HiTOP framework (Kotov et al., under review)— offers an alternative empirically supported model that provides a springboard to bring sexual dysfunctions into the broad psychopathology research framework.

Part 4: Implications and Future research

Reconceptualizing sexual dysfunctions as part of the internalizing spectrum and including them in HiTOP research could have exciting implications for sex research. For example, if low sexual function were recognized as an indicator of internalizing psychopathology, it might hopefully follow that population studies of mental health would be revised to include measures of sexual function. The lack of epidemiological data on sexual dysfunctions together with common mental disorders has been a big factor perpetuating the absence of sexual problems in psychopathology research, and good quality data on these relationships would be invaluable for sex researchers. This move could also help integrate sex research into mainstream psychology research, where sexual experiences are often only considered as of peripheral importance, as side effects or symptoms of ‘primary disorders’ (e.g., APA, 2013).

An additional benefit of including sexual problems in the new hierarchical and dimensional taxonomy of psychopathology would be to offer sex researchers a dimensional alternative to the categorical DSM model. This is important because sexual function is continuous (i.e., it does not naturally separate into discrete categories of ‘function’ and ‘dysfunction’), and phases of sexual response often overlap (Carvalho et al., 2012; Carvalho et al., 2011; Corona et al., 2015; Giles & McCabe, 2009). In contrast, the DSM deems sexual dysfunctions as either present or absent, and implies that low levels of arousal (e.g., Female Sexual Interest/Arousal Disorder, or Erectile Disorder) are categorically distinct from orgasmic function (e.g., Female Orgasmic Disorder, Premature [Early] Ejaculation, or Delayed Ejaculation). A move toward empirically validated models of characterizing low sexual function is also consistent with the National Institute of Mental Health’s move away from funding research based on DSM categories (Insel & Lieberman, 2013), and allows for the integration of sex research in the corresponding movement toward transdiagnostic treatment protocols, as well as proposed directions for neuroscience (i.e., focusing on the RDoC; Insel et al., 2010) and developmental psychology research (Forbes et al., 2016).

The finding that sexual problems likely share the underlying internalizing spectrum with depressive and anxiety disorders also has important implications for the diagnosis of sexual dysfunctions. Screening for depression and anxiety in presenting sexual dysfunction is already emphasized as important practice (Althof et al., 2005; APA, 2013). However, the reverse is not true, and sexual problems are underrecognized and undertreated (Bossini et al., 2014), despite their prevalence and impact. The presence of a shared transdiagnostic spectrum means that a history or current presentation of depressive or anxiety symptoms acts as an indicator to screen for distressing low sexual function. As mentioned earlier, this is a particularly important pattern of comorbidity to screen for, as it is associated with more chronic and severe symptoms across the board, more distress, resistance to treatment, poor long-term outcomes, and higher rates of suicidality (Bossini et al., 2014; Dell’Osso et al., 2009; Dobkin et al., 2006; Laurent & Simons, 2009; Michael & O’Keane, 2000). If our nosologies explicitly recognized the shared liability between low sexual function and other indicators of the internalizing spectrum, this could formalize the screening process and overcome some of the discomfort associated with initiating a conversation about sexual difficulties in primary care (Bossini et al., 2014).

These relationships also have implications for treatment. The high rates of comorbidity and shared treatment response between sexual dysfunctions and depressive and anxiety disorders undermine the efficacy and logic of treating them separately (cf. Nolen-Hoeksema & Watkins, 2011). The shared cognitive and emotional processing abnormalities noted earlier also highlight the exciting potential for efficacious transdiagnostic treatment programs that target the disorders concurrently. For example, transdiagnostic CBT programs have been developed that reduce the internalizing liability by targeting the shared mechanisms between depression and anxiety (e.g., Ellard, Fairholme, Boisseau, Farchione & Barlow, 2010; Kushner et al., 2013). The Unified Protocol is a transdiagnostic CBT program that distills the common principles of CBT treatment protocols for individual depressive and anxiety disorders, and includes many of the same techniques that are used to treat sexual dysfunctions, such as psychoeducation, mindfulness training, challenging maladaptive cognitions, and identifying and preventing avoidance (Barlow et al., 2010). To our knowledge, there are currently no transdiagnostic CBT programs to treat the comorbid presentation of depressive and anxiety disorders with sexual dysfunctions, so the extension of existing transdiagnostic CBT protocols could be a productive area for future research. It is likely that pharmacologic treatment will be an effective addition to these programs, and this should be investigated, as studies have suggested that neither medication nor psychotherapy alone is maximally effective for treating low sexual function (Althof et al., 2005; Heiman, 2002).

Of course, before transdiagnostic programs can be applied to sexual dysfunctions, the precise nature of the underlying mechanisms between the disorders will need to be investigated so that targeted treatment programs can be developed. As such, perhaps the most important area for future research is to define the transdiagnostic mechanisms between the disorders, and subsequently to determine whether they can be targeted effectively using transdiagnostic treatment (cf. Kessler & Price, 1993). To date, research on the overarching comorbidity between internalizing disorders and low sexual function has been based on a psychiatric epidemiology approach that focuses on the latent structure of the relationships and on the spectra of psychopathology (cf. Krueger & Markon, 2006). In order to extend this research to efficacious interventions, it will be essential to combine this approach with a focus on how the shared spectra manifest in specific cognitive, affective, and behavioral mechanisms (Harvey, Watkins, Mansell & Shafran, 2004). The shared characteristics found across internalizing disorders and low sexual function (e.g., distraction, worry, guilt, negative automatic thoughts, emotion dysregulation, rigid assumptions, avoidance; Carvalho et al., 2012; Nobre & Pinto-Gouveia, 2009) have been researched extensively in depression and anxiety, and Nobre and colleagues have begun research into these characteristics in sexual dysfunctions. However, the role of these characteristics has not been examined in comorbid disorder presentation. If they prove to be responsive to experimental interventions, as preliminary experimental results suggest may be the case (e.g., Kuffel & Heiman, 2006; ter Kuile et al., 2010), this could potentially lead to the development of transdiagnostic treatment programs (cf. Kessler & Price, 1993).

Lastly, the relationship between low sexual function and the internalizing spectrum highlights the possibility that other types of sexual behavior and experiences could be integrated into a hierarchical and dimensional model of psychopathology. For example, Eaton et al. (2015b) and Rodriguez-Seijas, Arfer, Thompson, Hasin, and Eaton (under review) have highlighted that sex-related drug and alcohol use may form part of the externalizing spectrum. The externalizing spectrum could also be related to other risky sexual behaviors, compulsive sexual behaviors, atypical sexual interests and behavior (e.g., attraction to sexual violence), or paraphilic disorders, as many share the characteristics of disinhibition and behavioral dyscontrol that characterize the externalizing spectrum (Justus, Finn & Steinmetz, 2000; Kafka, 2001; Testa & Collins, 1997; Wilson, 2010). Future research that integrates the range of sexual behavior and experience within the broader transdiagnostic framework would be a valuable avenue for future research.

Conclusion

Depression, anxiety, and sexual problems are highly prevalent. When combined, these phenomena have a profound negative impact, are resistant to treatment, and are associated with poor long-term outcomes for patients. A shared latent liability between the disorders evidently accounts for their comorbidity and interrelationships over time, and this finding offers the valuable opportunity to integrate sexual dysfunctions into an empirically derived taxonomy of psychopathology through the internalizing spectrum. Ultimately, these relationships can form the basis of new classification systems —evidence based nosologies— upon which empirically supported assessments and intervention can be built.

Acknowledgments

Role of Funding Source: This research was supported in part by a National Institute of Drug Abuse (NIDA) training grant supporting the work of Miriam Forbes (T320A037183). NIDA had no further role in the study design; in the collection, analysis, and interpretation of data; in writing; nor in the decision to submit the manuscript for publication.

Footnotes

1Symptoms of sexual dysfunctions —as delineated in the Diagnostic and Statistical Manual of Mental Disorders (DSM)— are collectively referred to as low sexual function throughout this review. This label is used to differentiate between diagnosed sexual dysfunctions with associated clinically significant distress, and the measurement of symptoms of these disorders without a formal diagnosis (cf. Bancroft, Loftus & Long, 2003b; Lutfey, Link, Rosen, Wiegel & McKinlay, 2009). Where diagnosed disorders (i.e., with accompanying distress) are referred to, the term “sexual dysfunctions” is used to correspond with the DSM.

2In this review, mental disorders (including sexual dysfunction) are conceptualized as syndromes indicated by groups of observable clinical symptoms and signs that commonly occur together. In this paradigm, the disorder itself is not observable; it is only measureable via its manifestations, which indicate the severity of the disorder on a continuous spectrum from ‘normal’ to ‘disordered’. The studies we review based on diagnoses (coded as present or absent) therefore have better criterion validity to the DSM disorder constructs, but lose valuable information about symptom variation above and below the diagnostic threshold (Krueger, Caspi, Moffit, & Silva, 1998). As such, we synthesize studies that focused on diagnosed disorders alongside studies that focused on continuous symptom measures, interpreting them together (i.e., with diagnoses interpreted as dichotomous indicators of disorder severity).

3This is how we use the term internalizing disorders in subsequent sections.

4In contrast, the co-occurrence of sexual dysfunctions with other domains of psychopathology has been attributed to the medications that are commonly used to treat schizophrenia and mania, for example (e.g., lithium and antipsychotics; Baggaley, 2008; de Boer, Castelein, Wiersma, Schoevers & Knegtering, 2015; Elnazer, Sampson & Baldwin, 2015).

5These estimates included the domains of desire, arousal sensation, lubrication, orgasm, and sexually-related distress for women; and the domains of erectile function, ejaculatory control and associated distress, and sexual satisfaction (operationalising low sexually-related distress) for men. The cognitive component of female sexual arousal had stronger relationships with the model (75–84% of its variance was accounted for by a longitudinal internalizing spectrum model), as expected. In contrast, female sexual pain and male sexual desire had weaker relationships (8–11% and 10–16% of their variance was accounted for, respectively), which is discussed in detail in Part 3.

6The models were not tested using a one-week or six-month gap for men because the subsample sizes were not large enough (Forbes et al., 2015a).

Conflict of Interest: The authors declare that they have no conflict of interest.

References

  • Abdolmanafi A, Azadfallah P, Fata L, Roosta M, Peixoto MM, Nobre P. Sexual Dysfunctional Beliefs Questionnaire (SDBQ): Translation and Psychometric Properties of the Iranian Version. The Journal of Sexual Medicine. 2015;12:1820–1827. doi: 10.1111/jsm.12931. [Abstract] [CrossRef] [Google Scholar]
  • Achenbach TM, Edelbrock CS. The classification of child psychopathology: A review and analysis of empirical efforts. Psychological Bulletin. 1978;85:1275–1301. [Abstract] [Google Scholar]
  • Achenbach TM, Edelbrock CS. Psychopathology of Childhood. Annual Review of Psychology. 1984;35:227–256. doi: 10.1146/annurev.ps.35.020184.001303. [Abstract] [CrossRef] [Google Scholar]
  • Aksaray G, Yelken B, Kaptanoglu C, Oflu S, Ozaltin M. Sexuality in women with obsessive compulsive disorder. Journal of Sex & Martial Therapy. 2001;27:273–277. doi: 10.1080/009262301750257128. [Abstract] [CrossRef] [Google Scholar]
  • Aksoy UM, Aksoy ŞG, Maner F, Gokalp P, Yanik M. Sexual dysfunction in obsessive compulsive disorder and panic disorder. Psychiatria Danubina. 2012;24:381–385. [Abstract] [Google Scholar]
  • Allen LB, McHugh RK, Barlow DH. Emotional disorders: A unified protocol 2008 [Google Scholar]
  • Althof SE, Leiblum SR, Chevret-Measson M, Hartmann U, Levine SB, McCabe M, Wylie K. Psychological and Interpersonal Dimensions of Sexual Function and Dysfunction. Journal of Sexual Medicine. 2005;2:793–800. doi: 10.1111/j.1743-6109.2005.00145.x. [Abstract] [CrossRef] [Google Scholar]
  • American Psychiatric Association. Diagnostic and statistical manual of mental disorders, (5th ed), International Version. Arlington, VA: American Psychiatric Publishing; 2013. [Google Scholar]
  • Andersson E, Walén C, Hallberg J, Paxling B, Dahlin M, Almlöv J, Andersson G. A Randomized Controlled Trial of Guided Internet-delivered Cognitive Behavioral Therapy for Erectile Dysfunction. The Journal of Sexual Medicine. 2011;8:2800–2809. doi: 10.1111/j.1743-6109.2011.02391.x. [Abstract] [CrossRef] [Google Scholar]
  • Andrews G, Goldberg DP, Krueger RF, Carpenter WTJ, Hyman SE, Sachdev P, Pine DS. Exploring the feasibility of a meta-structure for DSM-V and ICD-11: could it improve utility and validity? Psychological Medicine. 2009;39:1993–2000. doi: 10.1017/S0033291709990250. [Abstract] [CrossRef] [Google Scholar]
  • Andrews G, Morris-Yates A, Holt P, Henderson S. Evidence for a general neurotic syndrome. British Journal of Psychiatry. 1990;157:6–12. doi: 10.1192/bjp.157.1.6. [Abstract] [CrossRef] [Google Scholar]
  • Araujo AB, Durante R, Feldman HA, Goldstein I, McKinlay JB. The relationship between depressive symptoms and male erectile dysfunction: cross-sectional results from the Massachusetts male aging study. Psychosom Med. 1998;60 doi: 10.1097/00006842-199807000-00011. [Abstract] [CrossRef] [Google Scholar]
  • Atlantis E, Sullivan T. Bidirectional Association Between Depression and Sexual Dysfunction: A Systematic Review and Meta-Analysis. The Journal of Sexual Medicine. 2012;9:1497–1507. doi: 10.1111/j.1743-6109.2012.02709.x. [Abstract] [CrossRef] [Google Scholar]
  • Bach AK, Wincze JP, Barlow DH. Sexual Dysfunction. In: Barlow DH, editor. Clinical Handbook of Psychological Disorders: A Step-by-Step Treatment Manual – Fourth Edition. New York: The Guilford Press; 2007. [Google Scholar]
  • Baggaley M. Sexual dysfunction in schizophrenia: focus on recent evidence. Human Psychopharmacology: Clinical and Experimental. 2008;23:201–209. doi: 10.1002/hup.924. [Abstract] [CrossRef] [Google Scholar]
  • Baird AD, Wilson SJ, Bladin PF, Saling MM, Reutens DC. Neurological control of human sexual behaviour: insights from lesion studies. Journal of Neurology, Neurosurgery & Psychiatry. 2007;78:1042–1049. doi: 10.1136/jnnp.2006.107193. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
  • Baldwin DS. Depression and sexual function. Journal of psychopharmacology. 1996;10:30–34. [Google Scholar]
  • Baldwin DS. Depression and sexual dysfunction. British Medical Bulletin. 2001;57:81–99. doi: 10.1093/bmb/57.1.81. [Abstract] [CrossRef] [Google Scholar]
  • Balon R. Mood, anxiety, and physical illness: Body and mind, or mind and body. Depression and Anxiety. 2006a;23:377–387. doi: 10.1002/da.20217. [Abstract] [CrossRef] [Google Scholar]
  • Balon R. SSRI-associated sexual dysfunction. American Journal of Psychiatry. 2006b;163:1504–1509. [Abstract] [Google Scholar]
  • Balon R, Segraves RT, Clayton A. Issues for DSM-V: Sexual Dysfunction, Disorder, or Variation Along Normal Distribution: Toward Rethinking DSM Criteria of Sexual Dysfunctions. American Journal of Psychiatry. 2007;164:198–200. doi: 10.1176/ajp.2007.164.2.198. [Abstract] [CrossRef] [Google Scholar]
  • Bancroft J, Janssen E. The dual control model of male sexual response: A theoretical approach to centrally mediated erectile dysfunction. Neuroscience and Biobehavioral Reviews. 2000;24:571–579. [Abstract] [Google Scholar]
  • Bancroft J, Janssen E, Strong D, Carnes L, Vukadinovic Z, Long J. The relation between mood and sexuality in heterosexual men. Archives of Sexual Behavior. 2003a;32:217–230. doi: 10.1023/A:1023409516739. [Abstract] [CrossRef] [Google Scholar]
  • Bancroft J, Loftus J, Long J. Distress about sex: A national survey of women in heterosexual relationships. Archives of Sexual Behavior. 2003b;32:193–208. doi: 10.1023/A:1023420431760. [Abstract] [CrossRef] [Google Scholar]
  • Barlow DH. Causes of sexual dysfunction: the role of anxiety and cognitive interference. J Consult Clin Psychol. 1986;54 doi: 10.1037/0022-006x.54.2.140. [Abstract] [CrossRef] [Google Scholar]
  • Barlow DH, Farchione TJ, Fairholme CP, Ellard KK, Boisseau CL, Allen LB, Ehrenreich JT. Unified Protocol for Transdiagnostic Treatment of Emotional Disorders. Oxford University Press; 2010. [Google Scholar]
  • Basson R. The female sexual response: A different model. Journal of Sex & Marital Therapy. 2000;26:51–65. doi: 10.1080/009262300278641. [Abstract] [CrossRef] [Google Scholar]
  • Basson R. Using a different model for female sexual response to address women’s problematic low sexual desire. Journal of Sex & Marital Therapy. 2001;27:395–403. doi: 10.1080/713846827. [Abstract] [CrossRef] [Google Scholar]
  • Basson R. A model of women’s sexual arousal. Journal of Sex & Marital Therapy. 2002;28:1–10. doi: 10.1080/009262302317250963. [Abstract] [CrossRef] [Google Scholar]
  • Basson R. Women’s sexual dysfunction: Revised and expanded definitions. Canadian Medical Journal. 2005;172:1327–1333. doi: 10.1503/cmaj.1020174. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
  • Beard C, Amir N. Attention Bias for Sexual Words in Female Sexual Dysfunction. Journal of Sex & Marital Therapy. 2010;36:216–226. doi: 10.1080/00926231003719616. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
  • Beck AT. The development of depression: A cognitive model. In: Friedman R, Katz M, editors. Psychology of depression: Contemporary theory and research. Washington, DC: Winston-Wiley; 1974. [Google Scholar]
  • Beck AT. Cognitive therapy and the emotional disorders. New York: Meridan; 1979. [Google Scholar]
  • Berkson J. Limitations of the application of fourfold table analysis to hospital data. Biometrics Bulletin. 1946;2:47–53. doi: 10.2307/3002000. [Abstract] [CrossRef] [Google Scholar]
  • Binik YM, Reissing E, Pukall C, Flory N, Payne KA, Khalifé S. The female sexual pain disorders: Genital pain or sexual dysfunction? Archives of Sexual Behavior. 2002;31:425–429. doi: 10.1023/A:1019892125163. [Abstract] [CrossRef] [Google Scholar]
  • Black JS. Integrating medical and psychological treatment for sexual problems: the psyche and the soma. Sexual and Relationship Therapy. 2005;20:105–113. doi: 10.1080/14681990412331333928. [CrossRef] [Google Scholar]
  • Bocchio M, Pelliccione F, Mihalca R, Ciociola F, Necozione S, Rossi A, Francavilla S. Treatment of erectile dysfunction reduces psychological distress. International Journal of Andrology. 2009;32:74–80. doi: 10.1111/j.1365-2605.2007.00820.x. [Abstract] [CrossRef] [Google Scholar]
  • Bodinger L, Hermesh H, Aizenberg D, Valevski A, Marom S, Shiloh R, Weizman A. Sexual function and behavior in social phobia. The Journal of clinical psychiatry. 2002;63:1,478–879. [Abstract] [Google Scholar]
  • Boisseau CL, Farchione TJ, Fairholme CP, Ellard KK, Barlow DH. The development of the Unified Protocol for the transdiagnostic treatment of emotional disorders: A case study. Cognitive and Behavioral Practice. 2010;17:102–113. doi: 1077-7229/09/102-13. [Europe PMC free article] [Abstract] [Google Scholar]
  • Bossini L, Fortini V, Casolaro I, Caterini C, Koukouna D, Cecchini F, Fagiolini A. Sexual dysfunctions, psychiatric diseases and quality of life: A review. Psychiatria polska. 2014;48:715–726. [Abstract] [Google Scholar]
  • Bredt DS, Hwang PM, Glatt CE, Lowenstein C, Reed RR, Snyder SH. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature. 1991;351:714–718. doi: 10.1038/351714a0. [Abstract] [CrossRef] [Google Scholar]
  • Breyer BN, Cohen BE, Bertenthal D, Rosen RC, Neylan TC, Seal KH. Sexual Dysfunction in Male Iraq and Afghanistan War Veterans: Association with Posttraumatic Stress Disorder and Other Combat-Related Mental Health Disorders: A Population-Based Cohort Study. The Journal of Sexual Medicine. 2014;11:75–83. doi: 10.1111/jsm.12201. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
  • Brotto LA, Basson R, Luria M. A mindfulness-based group psychoeducational intervention targeting sexual arousal disorder in women. Journal of Sexual Medicine. 2008;5:1646–1659. doi: 10.1111/j.1743-6109.2008.00850.x. [Abstract] [CrossRef] [Google Scholar]
  • Brotto LA, Basson R, Smith KB, Driscoll M, Sadownik L. Mindfulness-based Group Therapy for Women with Provoked Vestibulodynia. Mindfulness. 2015;6:417–432. doi: 10.1007/s12671-013-0273-z. [CrossRef] [Google Scholar]
  • Brotto LA, Graham CA, Binik YM, Segraves RT, Zucker KJ. Should sexual desire and arousal disorders in women be merged? A response to DeRogatis, Clayton, Rosen, Sand, and Pyke (2010) Archives of Sexual Behavior. 2010 doi: 10.1007/s10508-010-9706-0. [CrossRef] [Google Scholar]
  • Brotto LA, Smith KB. The Wiley Blackwell Handbook of Mindfulness. John Wiley & Sons, Ltd; 2014. Applications of Mindfulness in the Treatment of Women’s Sexual Dysfunction; pp. 864–880. [Google Scholar]
  • Brotto LA, Woo J, Leiblum SR. Cognitive-behavioral and mindfulness-based therapy for low sexual desire. Treating sexual desire disorders: A clinical casebook. 2010:149–164. [Google Scholar]
  • Brown TA, Barlow DH. A proposal for a dimensional classification system based on the shared features of the DSM-IV anxiety and mood disorders: implications for assessment and treatment. Psychological Assessment. 2009;21:256. [Europe PMC free article] [Abstract] [Google Scholar]
  • Carragher N, Krueger RF, Eaton NR, Slade T. Disorders without borders: Current and future directions in the meta-structure of mental disorders. Social Psychiatry and Psychiatric Epidemiology. 2015;50:339–350. doi: 10.1007/s00127-014-1004-z. [Abstract] [CrossRef] [Google Scholar]
  • Carvalho J, Nobre PJ. Biopsychosocial Determinants of Men’s Sexual Desire: Testing an Integrative Model. The Journal of Sexual Medicine. 2011a;8:754–763. doi: 10.1111/j.1743-6109.2010.02156.x. [Abstract] [CrossRef] [Google Scholar]
  • Carvalho J, Nobre PJ. Predictors of Men’s Sexual Desire: The Role of Psychological, Cognitive-Emotional, Relational, and Medical Factors. The Journal of Sex Research. 2011b;48:254–262. doi: 10.1080/00224491003605475. [Abstract] [CrossRef] [Google Scholar]
  • Carvalho J, Vieira AL, Nobre PJ. Latent structures of female sexual functioning. Archives of Sexual Behavior. 2012;41:907–917. doi: 10.1007/s10508-011-9865-7. [Abstract] [CrossRef] [Google Scholar]
  • Carvalho J, Vieria AL, Nobre PJ. Latent structures of male sexual functioning. Journal of Sexual Medicine. 2011;8:2510–2511. doi: 10.1111/j.1743-6109.2011.02349.x. [Abstract] [CrossRef] [Google Scholar]
  • Cheng JYW, Ng EML, Ko JSN. Depressive symptomatology and male sexual functions in late life. Journal of Affective Disorders. 2007;104:225–229. doi: 10.1016/j.jad.2007.03.011. [Abstract] [CrossRef] [Google Scholar]
  • Chudakov B, Matar MA, Kaplan Z. A naturalistic prospective open study of the effects of adjunctive therapy of sexual dysfunction in chronic PTSD patients. The Israel journal of psychiatry and related sciences. 2008;45:26. [Abstract] [Google Scholar]
  • Clark LA, Watson D. Tripartite model of anxiety and depression: Psychometric evidence and taxonomic implications. Journal of Abnormal Psychology. 1991;100:316–336. doi: 10.1037//0021-843X.100.3.316. [Abstract] [CrossRef] [Google Scholar]
  • Clayton AH. Epidemiology and Neurobiology of Female Sexual Dysfunction. The Journal of Sexual Medicine. 2007;4:260–268. doi: 10.1111/j.1743-6109.2007.00609.x. [Abstract] [CrossRef] [Google Scholar]
  • Corona G, Rastrelli G, Limoncin E, Sforza A, Jannini EA, Maggi M. Interplay Between Premature Ejaculation and Erectile Dysfunction: A Systematic Review and Meta-Analysis. The Journal of Sexual Medicine. 2015;12:2291–2300. doi: 10.1111/jsm.13041. [Abstract] [CrossRef] [Google Scholar]
  • Corretti G, Baldi I. The relationship between anxiety disorders and sexual dysfunction. Psychiatric Times. 2007;24 Retrieved from http://www.psychiatrictimes.com/articles/relationship-between-anxiety-disorders-and-sexual-dysfunction-sthash.b4Vp7Peo.dpuf. [Google Scholar]
  • Corretti G, Pierucci S, De Scisciolo M, Nisita C. Comorbidity between social phobia and premature ejaculation: Study on 242 males affected by sexual disorders. Journal of Sex & Martial Therapy. 2006;32:183–187. doi: 10.1080/00926230500442342. [Abstract] [CrossRef] [Google Scholar]
  • Costa RM, Brody S. Greater resting heart rate variability is associated with orgasms through penile-vaginal intercourse, but not with orgasms from other sources. Journal of Sexual Medicine. 2012;9:188–197. [Abstract] [Google Scholar]
  • Cuntim M, Nobre P. The role of cognitive distraction on female orgasm. Sexologies. 2011;20:212–214. doi: 10.1016/j.sexol.2011.08.001. [CrossRef] [Google Scholar]
  • de Boer MK, Castelein S, Wiersma D, Schoevers RA, Knegtering H. The Facts About Sexual (Dys)function in Schizophrenia: An Overview of Clinically Relevant Findings. Schizophrenia Bulletin. 2015;41:674–686. doi: 10.1093/schbul/sbv001. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
  • Dell’Osso L, Carmassi C, Carlini M, Rucci P, Torri P, Cesari D, Maggi M. Sexual Dysfunctions and Suicidality in Patients with Bipolar Disorder and Unipolar Depression. The Journal of Sexual Medicine. 2009;6:3063–3070. doi: 10.1111/j.1743-6109.2009.01455.x. [Abstract] [CrossRef] [Google Scholar]
  • Derogatis LR, Meyer JK, King KM. Psychopathology in individuals with sexual dysfunction. American Journal of Psychiatry. 1981;138:757–763. [Abstract] [Google Scholar]
  • Dèttore D, Pucciarelli M, Santarnecchi E. Anxiety and Female Sexual Functioning: An Empirical Study. Journal of Sex & Marital Therapy. 2013;39:216–240. doi: 10.1080/0092623X.2011.606879. [Abstract] [CrossRef] [Google Scholar]
  • Dobkin RD, Leiblum SR, Rosen RC, Menza M, Marin H. Depression and Sexual Functioning in Minority Women: Current Status and Future Directions. Journal of Sex & Marital Therapy. 2006;32:23–36. doi: 10.1080/00926230500229251. [Abstract] [CrossRef] [Google Scholar]
  • Dosch A, Belayachi S, Van der Linden M. Implicit and Explicit Sexual Attitudes: How Are They Related to Sexual Desire and Sexual Satisfaction in Men and Women? The Journal of Sex Research. 2016;53:251–264. doi: 10.1080/00224499.2014.1003361. [Abstract] [CrossRef] [Google Scholar]
  • Dundon CM. The cortisol/DHEA ratio and sexual function in women with and without a history of depression. The University of Vermont and State Agricultural College; 2014. [Google Scholar]
  • Eaton NR. Transdiagnostic psychopathology factors and sexual minority mental health: Evidence of disparities and associations with minority stressors. Psychology of Sexual Orientation and Gender Diversity. 2014;1:244–254. doi: 10.1037/sgd0000048. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
  • Eaton NR, Krueger RF, Markon KE, Keyes KM, Skodol AE, Wall M, Grant BF. The structure and predictive validity of the internalizing disorders. Journal of Abnormal Psychology. 2013;122:86. doi: 10.1037/a0029598. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
  • Eaton NR, Krueger RF, Oltmanns TF. Aging and the structure and long-term stability of the internalizing spectrum of personality and psychopathology. Psychology and Aging. 2011;26:987–993. doi: 10.1037/a0024406. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
  • Eaton NR, Rodriguez-Seijas C, Carragher N, Krueger RF. Transdiagnostic factors of psychopathology and substance use disorders: A review. Social Psychiatry and Psychiatric Epidemiology. 2015a;50:171–182. doi: 10.1007/s00127-014-1001-2. [Abstract] [CrossRef] [Google Scholar]
  • Eaton NR, South SC, Krueger RF. The meaning of comorbidity among common mental disorders. In: Millon T, Krueger RF, Simonsen E, editors. Contemporary directions in psychopathology: Scientific foundations of the DSM-V and ICD-11. New York, NY, US: Guilford Press; 2010. pp. 223–241. [Google Scholar]
  • Eaton NR, Thompson RG, Hu MC, Goldstein RB, Saha TD, Hasin DS. Regularly Drinking Alcohol Before Sexual Activity in a Nationally Representative Sample: Prevalence, Sociodemographics, and Associations With Psychiatric and Substance Use Disorders. American Journal of Public Health. 2015b;105:1387–1393. doi: 10.2105/AJPH.2015.302556. [Abstract] [CrossRef] [Google Scholar]
  • Edwards AL. Introduction to linear regression and correlation. San Francisco, CA: W. H. Freeman and Co; 1976. [Google Scholar]
  • Ehring T, Watkins ER. Repetitive Negative Thinking as a Transdiagnostic Process. International Journal of Cognitive Therapy. 2008;1:192–205. doi: 10.1521/ijct.2008.1.3.192. [CrossRef] [Google Scholar]
  • Ellard KK, Fairholme CP, Boisseau CL, Farchione TJ, Barlow DH. Unified protocol for the transdiagnostic treatment of emotional disorders: protocol development and initial outcome data. Cognitive and Behavioral Practice. 2010;17:88–101. doi: 1077-7229/09/88-10. [Europe PMC free article] [Abstract] [Google Scholar]
  • Elliot AN, O’Donohue WT. The effects of anxiety and distraction on sexual arousal in a nonclinical sample of heterosexual women. Archives of Sexual Behavior. 1997;26:607–624. doi: 10.1016/j.brat.2005.08.006. [Abstract] [CrossRef] [Google Scholar]
  • Elnazer HY, Sampson A, Baldwin D. Lithium and sexual dysfunction: an under-researched area. Human Psychopharmacology: Clinical and Experimental. 2015;30:66–69. doi: 10.1002/hup.2457. [Abstract] [CrossRef] [Google Scholar]
  • Fabre LF, Clayton AH, Smith LC, Goldstein IM, Derogatis LR. Association of major depression with sexual dysfunction in men. The Journal of neuropsychiatry and clinical neurosciences. 2013;25:308–318. doi: 10.1176/appi.neuropsych.12010004. [Abstract] [CrossRef] [Google Scholar]
  • Fabre LF, Smith LC. The Effect of Major Depression on Sexual Function in Women. The Journal of Sexual Medicine. 2012;9:231–239. doi: 10.1111/j.1743-6109.2011.02445.x. [Abstract] [CrossRef] [Google Scholar]
  • Figueira I, Possidente E, Marques C, Hayes K. Sexual dysfunction: A neglected complication of panic disorder and social phobia. Archives of Sexual Behavior. 2001;30:369–377. doi: 10.1023/A:1010257214859. [Abstract] [CrossRef] [Google Scholar]
  • Forbes MK. Response to Rosen et al. (2014) “Commentary on ‘Critical Flaws in the FSFI and IIEF’” Journal of Sex Research. 2014;51:498–502. doi: 10.1080/00224499.2014.895795. [Abstract] [CrossRef] [Google Scholar]
  • Forbes MK, Baillie AJ, Schniering CA. Critical flaws in the Female Sexual Function Index and the International Index of Erectile Function. Journal of Sex Research. 2014;51:485–491. doi: 10.1080/00224499.2013.876607. [Abstract] [CrossRef] [Google Scholar]
  • Forbes MK, Baillie AJ, Schniering CA. A Structural Equation Modeling Analysis of the Relationships between Depression, Anxiety, and Sexual Problems over Time. The Journal of Sex Research. 2015a:1–13. doi: 10.1080/00224499.2015.1063576. [Abstract] [CrossRef] [Google Scholar]
  • Forbes MK, Baillie AJ, Schniering CA. Where Do Sexual Dysfunctions Fit into the Meta-Structure of Psychopathology? A Factor Mixture Analysis. Archives of Sexual Behavior. 2015b:1–14. doi: 10.1007/s10508-015-0613-2. [Abstract] [CrossRef] [Google Scholar]
  • Forbes MK, Baillie AJ, Schniering CA. Should Sexual Problems Be Included in the Internalizing Spectrum? A Comparison of Dimensional and Categorical Models. Journal of Sex & Marital Therapy. 2016;42:70–90. doi: 10.1080/0092623X.2014.996928. [Abstract] [CrossRef] [Google Scholar]
  • Forbes MK, Schniering CA. Are sexual problems a form of internalizing psychopathology? A structural equation modeling analysis. Archives of Sexual Behavior. 2013;42:23–44. doi: 10.1007/s10508-012-9948-0. [Abstract] [CrossRef] [Google Scholar]
  • Forbes MK, Tackett JL, Markon KE, Krueger RF. Beyond comorbidity: Toward a dimensional and hierarchal approach to understanding psychopathology across the lifespan. Development and Psychopathology. 2016;28:971–986. doi: 10.1017/S0954579416000651. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
  • Frohlich P, Meston M. Evidence that serotonin affects female sexual functioning via peripheral mechanisms. Physiology & Behavior. 2000;71:383–393. doi: 10.1016/S0031-9384(00)00344-9.. [Abstract] [CrossRef] [Google Scholar]
  • Frohlich P, Meston C. Sexual functioning and self-reported depressive symptoms among college women. Journal of Sex Research. 2002;39:321–326. doi: 10.1080/00224490209552156. [Abstract] [CrossRef] [Google Scholar]
  • Frühauf S, Gerger H, Schmidt HM, Munder T, Barth J. Efficacy of Psychological Interventions for Sexual Dysfunction: A Systematic Review and Meta-Analysis. Archives of Sexual Behavior. 2013;42:915–933. doi: 10.1007/s10508-012-0062-0. [Abstract] [CrossRef] [Google Scholar]
  • Giles K, McCabe M. Conceptualizing women’s sexual function: Linear vs. circular models of response. Journal of Sexual Medicine. 2009;6:2761–2771. doi: 10.1111/j.1743-6109.2009.01425.x. [Abstract] [CrossRef] [Google Scholar]
  • Giuliano F, Hellstrong WJ. The pharmacological treatment of premature ejaculation. BJU International. 2008;102:668–675. doi: 10.1111/j.1464-410X.2008.07719.x. [Abstract] [CrossRef] [Google Scholar]
  • Goldberg DP, Krueger RF, Andrews G, Hobbs MJ. Emotional Disorders: Cluster 4 of the proposed meta-structure for DSM-V and ICD-11. Psychological Medicine. 2009;39:2043–2059. doi: 10.1017/S0033291709990298. [Abstract] [CrossRef] [Google Scholar]
  • Hamilton LD, Julian AM. The Relationship Between Daily Hassles and Sexual Function in Men and Women. Journal of Sex & Marital Therapy. 2014;40:379–395. doi: 10.1080/0092623X.2013.864364. [Abstract] [CrossRef] [Google Scholar]
  • Harris JM, Cherkas LF, Kato BS, Heiman JR, Spector TD. Normal variations in personality are associated with coital orgasmic infrequency in heterosexual women: a population-based study. Journal of Sexual Medicine. 2008;5:1177–1183. doi: 10.1111/j.1743-6109.2008.00800.x. [Abstract] [CrossRef] [Google Scholar]
  • Harvey AG, Watkins ER, Mansell W, Shafran R. Cognitive behavioural processes across psychological disorders: A transdiagnostic approach to research and treatment. Oxford: Oxford University Press; 2004. [Google Scholar]
  • Hayes RD, Dennerstein L, Bennett CM, Sidat M, Gurrin LC, Fairley CK. Risk Factors for Female Sexual Dysfunction in the General Population: Exploring Factors Associated with Low Sexual Function and Sexual Distress. The Journal of Sexual Medicine. 2008;5:1681–1693. doi: 10.1111/j.1743-6109.2008.00838.x. [Abstract] [CrossRef] [Google Scholar]
  • Heiman J. Psychologic treatments for female sexual dysfunction: Are they effective and do we need them? Archives of Sexual Behavior. 2002;31:445–450. doi: 10.1023/A:1019848310142. [Abstract] [CrossRef] [Google Scholar]
  • Hirsch KA. Sexual dysfunction in male Operation Enduring Freedom/Operation Iraqi Freedom patients with severe post-traumatic stress disorder. Mil Med. 2009;174:520–522. [Abstract] [Google Scholar]
  • Hirschfeld RM. History and evolution of the monoamine hypothesis of depression. The Journal of Clinical Psychiatry. 2000;61:1,478–476. [Google Scholar]
  • Hoehn-Saric R, McLeod DR. The peripheral sympathetic nervous system. Its role in normal and pathologic anxiety. The Psychiatric clinics of North America. 1988;11:375–386. [Abstract] [Google Scholar]
  • Hollon SD, Stewart MO, Strunk D. Enduring Effects for Cognitive Behavior Therapy in the Treatment of Depression and Anxiety. Annual Review of Psychology. 2006;57:285–315. doi: 10.1146/annurev.psych.57.102904.190044. [Abstract] [CrossRef] [Google Scholar]
  • Hoyer J, Uhmann S, Rambow J, Jacobi F. Reduction of sexual dysfunction: By-product of cognitive-behavioral therapy for psychological disorders? Sexual and Relationship Therapy. 2009;24:64–73. doi: 10.1080/14681990802649938. [CrossRef] [Google Scholar]
  • Insel TR, Lieberman JA. DSM-5 and RDoC: Shared Interests. 2013 Retrieved June, 2013, from http://www.nimh.nih.gov/news/science-news/2013/dsm-5-and-rdoc-shared-interests.shtml.
  • Insel TR, Cuthbert B, Garvey M, Heinssen R, Pine DS, Quinn K, Sanislow C, Wang P. Research Domain Criteria (RDoC): Toward a New Classification Framework for Research on Mental Disorders. American Journal of Psychiatry. 2010;167:748–751. [Abstract] [Google Scholar]
  • Jones LM, McCabe MP. The effectiveness of an internet-based psychological treatment program for female sexual dysfunction. Journal of Sexual Medicine. 2011;8:2781–2792. doi: 10.1111/j.1743-6109.2011.02381.x. [Abstract] [CrossRef] [Google Scholar]
  • Justus AN, Finn PR, Steinmetz JE. The Influence of Traits of Disinhibition on the Association Between Alcohol Use and Risky Sexual Behavior. Alcoholism: Clinical and Experimental Research. 2000;24:1028–1035. doi: 10.1111/j.1530-0277.2000.tb04646.x. [Abstract] [CrossRef] [Google Scholar]
  • Kafka MP. The Paraphilia-Related Disorders: A Proposal for a Unified Classification of Nonparaphilic Hypersexuality Disorders. Sexual Addiction & Compulsivity. 2001;8:227–239. doi: 10.1080/107201601753459937. [CrossRef] [Google Scholar]
  • Kalmbach DA, Ciesla JA, Janata JW, Kingsberg SA. Specificity of anhedonic depression and anxious arousal with sexual problems among sexually healthy young adults. Journal of Sexual Medicine. 2012;9:505–513. doi: 10.1111/j.1743-6109.2011.02533.x. [Abstract] [CrossRef] [Google Scholar]
  • Kalmbach DA, Kingsberg SA, Ciesla JA. How Changes in Depression and Anxiety Symptoms Correspond to Variations in Female Sexual Response in a Nonclinical Sample of Young Women: A Daily Diary Study. The Journal of Sexual Medicine. 2014;11:2915–2927. doi: 10.1111/jsm.12692. [Abstract] [CrossRef] [Google Scholar]
  • Kalmbach DA, Pillai V. Daily Affect and Female Sexual Function. The Journal of Sexual Medicine. 2014;11:2938–2954. doi: 10.1111/jsm.12712. [Abstract] [CrossRef] [Google Scholar]
  • Kalmbach DA, Pillai V, Kingsberg SA, Ciesla JA. The Transaction Between Depression and Anxiety Symptoms and Sexual Functioning: A Prospective Study of Premenopausal, Healthy Women. Archives of Sexual Behavior. 2015;44:1635–1649. doi: 10.1007/s10508-014-0381-4. [Abstract] [CrossRef] [Google Scholar]
  • Kaplan HS. Disorders of sexual desire and other new concepts and techniques in sex therapy. Bruner Meisel U; 1979. [Google Scholar]
  • Kaya B, Unal S, Ozenli Y, Gursoy N, Tekiner S, Kafkasli A. Anxiety, depression and sexual dysfunction in women with chronic pelvic pain. Sexual and Relationship Therapy. 2006;21:187–196. doi: 10.1080/14681990500359897. [CrossRef] [Google Scholar]
  • Keks N, Hope J, Culhane C. Management of antidepressant-induced sexual dysfunction. Australasian Psychiatry. 2014;22(6):525–528. [Abstract] [Google Scholar]
  • Kemp AH, Quintana DS, Felmingham KL, Matthews S, Jelinek HF. Depression, comorbid anxiety disorders, and heart rate variability in physically healthy, unmedicated patients: Implications for cardiovascular risk. PloS one. 2012;7(2):e30777. doi: 10.1371/journal.pone.0030777. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
  • Kemp AH, Quintana DS, Gray MA, Felmingham KL, Brown K, Gatt JM. Impact of depression and antidepressant treatment on heart rate variability: A review and meta-analysis. Biological Psychiatry. 2010;67:1067–1074. doi: 10.1016/j.biopsych.2009.12.012. [Abstract] [CrossRef] [Google Scholar]
  • Kendler KS. Introduction to ‘A proposal for a meta-structure for DSM-V and ICD-11’ Psychological Medicine. 2009;39:1991. doi: 10.1017/S0033291709991772. [CrossRef] [Google Scholar]
  • Kendurkar A, Kaur B. Major Depressive Disorder, Obsessive-Compulsive Disorder, and Generalized Anxiety Disorder: Do the Sexual Dysfunctions Differ? Primary Care Companion to The Journal of Clinical Psychiatry. 2008;10:299–305. [Europe PMC free article] [Abstract] [Google Scholar]
  • Kennedy S, Dickens S, Eisfeld B, Bagby M. Sexual dysfunction before antidepressant therapy in major depression. Journal of Affective Disorders. 1999;56:201–208. doi: 10.1016/S0165-0327(99)00050-6. [Abstract] [CrossRef] [Google Scholar]
  • Kessler RC, Chiu WT, Demler O, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry. 2005;62:617–627. doi: 10.1001/archpsyc.62.6.617. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
  • Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Kendler KS. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Archives of General Psychiatry. 1994;51:8–19. doi: archpsyc.1994.03950010008002. [Abstract] [Google Scholar]
  • Kessler RC, Ormel J, Petukhova M, McLaughlin KA, Green JG, Russo LJ, Ustun TB. Development of lifetime comorbidity in the World Health Organization world mental health surveys. Archives of General Psychiatry. 2011;68:90–100. doi: 10.1001/archgenpsychiatry.2010.180. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
  • Kessler RC, Price RH. Primary prevention of secondary disorders: A proposal and agenda. American Journal of Community Psychology. 1993;21:607. doi: 10.1007/BF00942174. [Abstract] [CrossRef] [Google Scholar]
  • Kim HK, Eaton NR. The hierarchical structure of common mental disorders: Connecting multiple levels of comorbidity, bifactor models, and predictive validity. Journal of Abnormal Psychology (in press) [Abstract] [Google Scholar]
  • Kotov R, Krueger RF, Watson D, Achenbach TM, Althoff RR, Bagby M, Zimmerman M. The hierarchical taxonomy of psychopathology (HiTOP): A dimensional alternative to traditional nosologies. (under review) [Abstract] [Google Scholar]
  • Krueger RF. The structure of common mental disorders. Archives of General Psychiatry. 1999;56:921–926. doi: 10.1001/archpsyc.56.10.921. [Abstract] [CrossRef] [Google Scholar]
  • Krueger RF, Caspi A, Moffit T, Silva P. The structure and stability of common mental disorders (DSM-III-R): A longitudinal-epidemiological study. Journal of Abnormal Psychology. 1998;107:216–227. doi: 10.1037//0021-843X.107.2.216. [Abstract] [CrossRef] [Google Scholar]
  • Krueger RF, Eaton NR. Transdiagnostic factors of mental disorders. World Psychiatry. 2015;14:27–29. doi: 10.1002/wps.20175. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
  • Krueger RF, Finger M. Using item response theory to understand comorbidity among anxiety and unipolar mood disorders. Psychological Assessment. 2001;13:140–151. doi: 10.1037//1040-3590.13.1.140. [Abstract] [CrossRef] [Google Scholar]
  • Krueger RF, Markon KE. Reinterpreting comorbidity: A model-based approach to understanding and classifying psychopathology. Annual Review of Clinical Psychology. 2006;2:111–133. doi: 10.1146/annurev.clinpsy.2.022305.095213. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
  • Krueger RF, Markon KE, Patrick CJ, Benning SD, Kramer MD. Linking antisocial behavior, substance use, and personality: An integrative quantitative model of the adult externalizing spectrum. Journal of Abnormal Psychology. 2007;116:645–666. doi: 10.1037/0021-843X.116.4.645. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
  • Krueger RF, Markon KE, Patrick CJ, Iacono WG. Externalizing psychopathology in adulthood: A dimensional-spectrum conceptualization and its implications for DSM-V. Journal of Abnormal Psychology. 2005;114:537–550. doi: 10.1037/0021-843X.114.4.537. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
  • Krueger RF, Piasecki TM. Toward a dimensional and psychometrically-informed approach to conceptualizing psychopathology. Behaviour Research and Therapy. 2002;40:485–499. doi: 10.1016/S0005-7967(02)00016-5. [Abstract] [CrossRef] [Google Scholar]
  • Krueger RF, Watson D, Barlow DH. Introduction to the special section: Toward a dimensionally based taxonomy of psychopathology. Journal of Abnormal Psychology. 2005;114:491–493. doi: 10.1037/0021-843X.114.4.491. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
  • Kuffel WS, Heiman JR. Effects of Depressive Symptoms and Experimentally Adopted Schemas on Sexual Arousal and Affect in Sexually Healthy Women. Archives of Sexual Behavior. 2006;35:160–174. doi: 10.1007/s10508-005-9015-1. [Abstract] [CrossRef] [Google Scholar]
  • Kushner MG, Krueger RF, Wall MM, Maurer EW, Menk JS, Menary KR. Modeling and treating internalizing psychopathology in a clinical trial: A latent variable structural equation modeling approach. Psychological Medicine. 2013:1–13. doi: 10.1017/S0033291712002772. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
  • Lahey BB, Zald DH, Hakes JK, Krueger RF, Rathouz PJ. Patterns of heterotypic continuity associated with the cross-sectional correlational structure of prevalent mental disorders in adults. JAMA Psychiatry. 2014;71:989–996. doi: 10.1001/jamapsychiatry.2014.359. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
  • Laurent SM, Simons AD. Sexual dysfunction in depression and anxiety: Conceptualizing sexual dysfunction as part of an internalizing dimension. Clinical Psychology Review. 2009;29:573–585. doi: 10.1016/j.cpr.2009.06.007. [Abstract] [CrossRef] [Google Scholar]
  • Lee JY, Joo K-J, Kim JT, Cho ST, Cho DS, Won YY, Choi JB. Heart rate variability in men with erectile dysfunction. International Neurology Journal. 2011;15:87–91. doi: 10.5213/inj.2011.15.2.87. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
  • Ramsey JM, Cooper JD, Bot M, Guest PC, Lamers F, Weickert CS, Bahn D. Sex differences in serum markers of major depressive disorder in the Netherlands Study of Depression and Anxiety (NESDA) Plos One. 2016;11:e0155624. doi: 10.1371/journal.pone.0156624. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
  • Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA. 1999;281(6):537–544. doi: 10.1001/jama.281.6.537. [Abstract] [CrossRef] [Google Scholar]
  • Lee BH, Kim YK. The Roles of BDNF in the Pathophysiology of Major Depression and in Antidepressant Treatment. Psychiatry Investigation. 2010;7(4):231–235. http://doi.org/10.4306/pi.2010.7.4.231. [Europe PMC free article] [Abstract] [Google Scholar]
  • Levine S. Influence of psychological variables on the activity of the hypothalamic-pituitary-adrenal axis. European journal of pharmacology. 2000;405:149–160. doi: 10.1016/s0014-2999(00)00548-3. [Abstract] [CrossRef] [Google Scholar]
  • Lewis RW, Fugl-Meyer KS, Corona G, Hayes RD, Laumann EO, Moreira ED, Jr, Segraves T. ORIGINAL ARTICLES: Definitions/Epidemiology/Risk Factors for Sexual Dysfunction. The Journal of Sexual Medicine. 2010;7:1598–1607. doi: 10.1111/j.1743-6109.2010.01778.x. [Abstract] [CrossRef] [Google Scholar]
  • Lorenz TK, Harte CB, Meston CM. Changes in Autonomic Nervous System Activity are Associated with Changes in Sexual Function in Women with a History of Childhood Sexual Abuse. The Journal of Sexual Medicine. 2015;12:1545–1554. doi: 10.1111/jsm.12908. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
  • Lutfey K, Link C, Rosen R, Wiegel M, McKinlay J. Prevalence and correlates of sexual activity and function in women: Results from the Boston Area Community Health (BACH) Survey. Archives of Sexual Behavior. 2009;38:514–527. doi: 10.1007/s10508-007-9290-0. [Abstract] [CrossRef] [Google Scholar]
  • Madioni F, Mammana LA. Toronto Alexithymia Scale in Outpatients with Sexual Disorders. Psychopathology. 2001;34:95–98. [Abstract] [Google Scholar]
  • Marchesi C, Brusamonti E, Maggini C. Are alexithymia, depression, and anxiety distinct constructs in affective disorders? J Psychosom Res. 2000;49:43–49. [Abstract] [Google Scholar]
  • Markon KE. Modeling psychopathology structure: A symptom-level analysis of Axis I and II disorders. Psychological Medicine. 2010;40:273–288. doi: 10.1017/S0033291709990183. [Abstract] [CrossRef] [Google Scholar]
  • Masters WH, Johnson VE. Human sexual inadequacy. Toronto, New York: Bantam Books; 1970. [Google Scholar]
  • McCabe MP. Evaluation of a Cognitive Behavior Therapy Program for People with Sexual Dysfunction. Journal of Sex & Marital Therapy. 2001;27:259–271. doi: 10.1080/009262301750257119. [Abstract] [CrossRef] [Google Scholar]
  • McCabe MP, Althof SE. A Systematic Review of the Psychosocial Outcomes Associated with Erectile Dysfunction: Does the Impact of Erectile Dysfunction Extend Beyond a Man’s Inability to Have Sex? The Journal of Sexual Medicine. 2014;11:347–363. doi: 10.1111/jsm.12374. [Abstract] [CrossRef] [Google Scholar]
  • McCabe MP, Connaughton C. Psychosocial Factors Associated with Male Sexual Difficulties. The Journal of Sex Research. 2014;51:31–42. doi: 10.1080/00224499.2013.789820. [Abstract] [CrossRef] [Google Scholar]
  • McCabe MP, Sharlip ID, Lewis RW, Atalla E, Balon R, Fisher AD, Segraves RT. Incidence and Prevalence of Sexual Dysfunction in Women and Men: A Consensus Statement from the Fourth International Consultation on Sexual Medicine 2015. The Journal of Sexual Medicine. 2016;13:144–152. doi: 10.1016/j.jsxm.2015.12.034. [Abstract] [CrossRef] [Google Scholar]
  • Meston CM. Sympathetic nervous system activity and female sexual arousal. American Journal of Cardiology. 2000;86:30–34. doi: 10.1016/S0002-9149(00)00889-4. [Abstract] [CrossRef] [Google Scholar]
  • Meston CM, Frohlich PF. The neurobiology of sexual function. Archives of General Psychiatry. 2000;57:1012–1030. doi: 10.1001/archpsyc.57.11.1012. [Abstract] [CrossRef] [Google Scholar]
  • Meston CM, Gorzalka BB. Differential effects of sympathetic activation on sexual arousal in sexually dysfunctional and functional women. J Abnorm Psychol. 1996;105:582–591. [Abstract] [Google Scholar]
  • Michael A, Keane V. Sexual dysfunction in depression. Human Psychopharmacology: Clinical and Experimental. 2000;15:337–345. doi: 10.1002/1099-1077. [Abstract] [CrossRef] [Google Scholar]
  • Michetti PM, Rossi R, Bonanno D, De Dominicis C, Iori F, Simonelli C. Dysregulation of Emotions and Premature Ejaculation (PE): Alexithymia in 100 Outpatients. The Journal of Sexual Medicine. 2007;4:1462–1467. doi: 10.1111/j.1743-6109.2007.00564.x. [Abstract] [CrossRef] [Google Scholar]
  • Mills AC, Grant DM, Judah MR, White EJ, Taylor DL, Frosio KE. Trait attentional control influences the relationship between repetitive negative thinking and psychopathology symptoms. Psychiatry Research. 2016;238:277–283. doi: 10.1016/j.psychres.2016.02.055. [Abstract] [CrossRef] [Google Scholar]
  • Miner MM, Seftel AD. Centrally acting mechanisms for the treatment of male sexual dysfunction. The Urologic Clinics of North America. 2007;34:483–496. doi: 10.1016/j.ucl.2007.08.008. [Abstract] [CrossRef] [Google Scholar]
  • Mohammadi SD, Mohammadkhani P, Dolatshahi B, Dadkhah A. Effectiveness of cognitive behavioral therapy on the signs, symptoms and clinical consequences of premature ejaculation. Japanese Psychological Research. 2013;55:350–357. doi: 10.1111/jpr.12020. [CrossRef] [Google Scholar]
  • Moyano N, Sierra JC. Relationships between personality traits and positive/negative sexual cognitions. International Journal of Clinical and Health Psychology. 2013;13:189–196. doi: 10.1016/S1697-2600(13)70023-1. [CrossRef] [Google Scholar]
  • Moynihan R. The making of a disease: female sexual dysfunction. British Medical Journal. 2003;326:45. [Europe PMC free article] [Abstract] [Google Scholar]
  • Munoz V, Stravynski A. Social phobia and sexual problems: A comparison of social phobic, sexually dysfunctional and normal individuals. British Journal of Clinical Psychology. 2010;49:53–66. doi: 10.1348/014466509X436697. [Abstract] [CrossRef] [Google Scholar]
  • Nicolosi A, Moreira ED, Villa M, Glasser DB. A population study of the association between sexual function, sexual satisfaction and depressive symptoms in men. J Affect Disord. 2004;82 doi: 10.1016/j.jad.2003.12.008. [Abstract] [CrossRef] [Google Scholar]
  • Nobre PJ. Determinants of sexual desire problems in women: testing a cognitive-emotional model. Journal of Sex & Marital Therapy. 2009;35:360–377. doi: 10.1080/00926230903065716. [Abstract] [CrossRef] [Google Scholar]
  • Nobre PJ, Pinto-Gouveia J. Dysfunctional sexual beliefs as vulnerability factors for sexual dysfunction. Journal of Sex Research. 2006a;43:68–75. doi: 10.1080/00224490609552300. [Abstract] [CrossRef] [Google Scholar]
  • Nobre PJ, Pinto-Gouveia J. Emotions During Sexual Activity: Differences Between Sexually Functional and Dysfunctional Men and Women. Archives of Sexual Behavior. 2006b;35:491–499. doi: 10.1007/s10508-006-9047-1. [Abstract] [CrossRef] [Google Scholar]
  • Nobre PJ, Pinto-Gouveia J. Cognitions, emotions, and sexual response: analysis of the relationship among automatic thoughts, emotional responses, and sexual arousal. Arch Sex Behav. 2008a;37 doi: 10.1007/s10508-007-9258-0. [Abstract] [CrossRef] [Google Scholar]
  • Nobre PJ, Pinto-Gouveia J. Cognitive and emotional predictors of female sexual dysfunctions: preliminary findings. Journal of Sex & Marital Therapy. 2008b;34:325–342. doi: 10.1080/00926230802096358. [Abstract] [CrossRef] [Google Scholar]
  • Nobre PJ, Pinto-Gouveia J. Differences in Automatic Thoughts Presented During Sexual Activity Between Sexually Functional and Dysfunctional Men and Women. Cognitive Therapy and Research. 2008c;32:37–49. doi: 10.1007/s10608-007-9165-7. [CrossRef] [Google Scholar]
  • Nobre PJ, Pinto-Gouveia J. Cognitive schemas associated with negative sexual events: A comparison of men and women with and without sexual dysfunction. Archives of Sexual Behavior. 2009;38:842–851. doi: 10.1007/s10508-008-9450-x. [Abstract] [CrossRef] [Google Scholar]
  • Nofzinger EA, Thase ME, Reynolds CF, Frank E, Jennings R, Garamoni GL, Kupfer DJ. Sexual function in depressed men: assessment by self-report, behavioral, and nocturnal penile tumescence measures before and after treatment with cognitive behavior therapy. Archives of General Psychiatry. 1993;50:24–30. doi: archpsyc.1993.01820130026005. [Abstract] [Google Scholar]
  • Nolen-Hoeksema S, Watkins ER. A Heuristic for Developing Transdiagnostic Models of Psychopathology: Explaining Multifinality and Divergent Trajectories. Perspectives on Psychological Science. 2011;6:589–609. doi: 10.1177/1745691611419672. [Abstract] [CrossRef] [Google Scholar]
  • O’Connor B. The search for dimensional structure differences between normality and abnormality: A statistical review of published data on personality and psychopathology. Journal of Personality and Social Psychology. 2002;83:962–982. doi: 10.1037/0022-3514.83.4.962. [Abstract] [CrossRef] [Google Scholar]
  • Oliveira C, Laja P, Carvalho J, Quinta Gomes AL, Vilarinho S, Janssen E, Nobre PJ. Predictors of men’s sexual response to erotic film stimuli: the role of affect and self-reported thoughts. J Sex Med. 2014;11:2701–2708. doi: 10.1111/jsm.12650. [Abstract] [CrossRef] [Google Scholar]
  • Oliveira C, Nobre PJ. Cognitive Structures in Women with Sexual Dysfunction: The Role of Early Maladaptive Schemas. The Journal of Sexual Medicine. 2013a;10:1755–1763. doi: 10.1111/j.1743-6109.2012.02737.x. [Abstract] [CrossRef] [Google Scholar]
  • Oliveira C, Nobre PJ. The role of trait-affect, depression, and anxiety in women with sexual dysfunction: a pilot study. Journal of Sex & Marital Therapy. 2013b;39:436–452. doi: 10.1080/0092623X.2012.665813. [Abstract] [CrossRef] [Google Scholar]
  • Palace E, Gorzalka B. The enhancing effects of anxiety on arousal in sexually dysfunctional and functional women. Journal of Abnormal Psychology. 1990;99:403–411. doi: 10.1037/0021-843X.99.4.403. [Abstract] [CrossRef] [Google Scholar]
  • Pariante CM, Lightman SL. The HPA axis in major depression: classical theories and new developments. Trends in Neurosciences. 2008;31:464–468. doi: 10.1016/j.tins.2008.06.006. [Abstract] [CrossRef] [Google Scholar]
  • Peixoto MM, Nobre PJ. Trait-affect, depressed mood, and male sexual functioning: A preliminary study. Journal of Sexual Medicine. 2012 doi: 10.1111/j.1743-6109.2012.02779.x. [Abstract] [CrossRef] [Google Scholar]
  • Peixoto MM, Nobre PJ. Dysfunctional sexual beliefs: a comparative study of heterosexual men and women, gay men, and lesbian women with and without sexual problems. J Sex Med. 2014;11:2690–2700. doi: 10.1111/jsm.12666. [Abstract] [CrossRef] [Google Scholar]
  • Peixoto MM, Nobre PJ. Cognitive Schemas Activated in Sexual Context: A Comparative Study with Homosexual and Heterosexual Men and Women, With and Without Sexual Problems. Cognitive Therapy and Research. 2015;39:390–402. doi: 10.1007/s10608-014-9661-5. [CrossRef] [Google Scholar]
  • Peixoto MM, Nobre PJ. Positive and Negative Affect During Sexual Activity: Differences Between Homosexual and Heterosexual Men and Women, With and Without Sexual Problems. Journal of Sex & Marital Therapy. 2016;42:4–17. doi: 10.1080/0092623X.2014.996929. [Abstract] [CrossRef] [Google Scholar]
  • Peleg-Sagy T, Shahar G. The Prospective Associations Between Depression and Sexual Satisfaction among Female Medical Students. The Journal of Sexual Medicine. 2013;10:1737–1743. doi: 10.1111/jsm.12176. [Abstract] [CrossRef] [Google Scholar]
  • Pinto-Gouveia J, Castilho P, Galhardo A, Cunha M. Early Maladaptive Schemas and Social Phobia. Cognitive Therapy and Research. 2006;30:571–584. doi: 10.1007/s10608-006-9027-8. [CrossRef] [Google Scholar]
  • Preskorn SH, Ross R, Stanga CY. Selective Serotonin Reuptake Inhibitors. In: Preskorn SH, Ross R, editors. Antidepressants: Past, Present, and Future. Berlin: Springer; 2004. pp. 241–262. [Google Scholar]
  • Quinta Gomes AL, Nobre PJ. Personality traits and psychopathology on male sexual dysfunction: an empirical study. Journal of Sexual Medicine. 2011;8:461–469. doi: 10.1111/j.1743-6109.2010.02092.x. [Abstract] [CrossRef] [Google Scholar]
  • Quinta Gomes AL, Nobre PJ. Early Maladaptive Schemas and Sexual Dysfunction in Men. Archives of Sexual Behavior. 2012;41:311–320. doi: 10.1007/s10508-011-9853-y. [Abstract] [CrossRef] [Google Scholar]
  • Rajkumar RP, Kumaran AK. Depression and anxiety in men with sexual dysfunction: a retrospective study. Compr Psychiatry. 2015;60:114–118. doi: 10.1016/j.comppsych.2015.03.001. [Abstract] [CrossRef] [Google Scholar]
  • Redmond D, Kosten T, Reiser M. Spontaneous ejaculation associated with anxiety: psychophysiological considerations. American Journal of Psychiatry. 1983;140:1163–1166. [Abstract] [Google Scholar]
  • Rodriguez-Seijas C, Arfer KB, Thompson RG, Hasin DS, Eaton NR. Sex-related Substance Use and the Externalizing Spectrum. Drug and Alcohol Dependence (under review) [Abstract] [Google Scholar]
  • Rodriguez-Seijas C, Stohl M, Hasin DS, Eaton NR. Transdiagnostic factors and mediation of the relationship between perceived racial discrimination and mental disorders. JAMA Psychiatry. 2015;72:706–713. doi: 10.1001/jamapsychiatry.2015.0148. [Abstract] [CrossRef] [Google Scholar]
  • Rosen RC, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, D’Agostino R. The Female Sexual Function Index (FSFI): A multidimensional self-report instrument for the assessment of female sexual function. Journal of Sex & Marital Therapy. 2000;26:191–208. doi: 10.1080/009262300278597. [Abstract] [CrossRef] [Google Scholar]
  • Rosen RC, Leiblum SR, Spector IP. Psychologically based treatment for male erectile disorder: A cognitive-interpersonal model. Journal of Sex & Marital Therapy. 1994;20:67–85. doi: 10.1080/00926239408403419. [Abstract] [CrossRef] [Google Scholar]
  • Sbrocco T, Barlow DH. Conceptualizing the cognitive component of sexual arousal: Implications for sexuality research and treatment. Frontiers of cognitive therapy. 1996:419–449. [Google Scholar]
  • Schatzberg AF, Cole JO, DeBattista C. Antidepressants. In: Schatzberg AF, Cole JO, DeBattista C, editors. Manual of clinicl psychopharmacology. 6th. Arlington, VA: American Psychiatric Publishing; 2007. pp. 37–168. [Google Scholar]
  • Schatzberg AF, Nemeroff CB. The. 4th. American Psychiatric Publishing textbook of psychopharmacology; Arlington, VA: American Psychiatric Publishing; 2009. [Google Scholar]
  • Schmidt NB, Joiner TE, Young JE, Telch MJ. The schema questionnaire: Investigation of psychometric properties and the hierarchical structure of a measure of maladaptive schemas. Cognitive Therapy and Research. 1995;19:295–321. doi: 10.1007/bf02230402. [CrossRef] [Google Scholar]
  • Schnurr PP, Lunney CA, Forshay E, Thurston VL, Chow BK, Resick PA, Foa EB. Sexual Function Outcomes in Women Treated for Posttraumatic Stress Disorder. Journal of Women’s Health. 2009;18:1549–1557. doi: 10.1089/jwh.2008.1165. [Abstract] [CrossRef] [Google Scholar]
  • Segraves RT. Effects of psychotropic drugs on human erection and ejaculation. Archives of General Psychiatry. 1989;46:275–284. [Abstract] [Google Scholar]
  • Seidman SN, Roose SP. The relationship between depression and erectile dysfunction. Current Psychiatry Reports. 2000;2:201–205. doi: 10.1007/s11920-996-0008-0. [Abstract] [CrossRef] [Google Scholar]
  • Spector I, Carey M, Steinberg L. The sexual desire inventory: Development, factor structure, and evidence of reliability. Journal of Sex & Marital Therapy. 1996;22:175–190. doi: 10.1080/00926239608414655. [Abstract] [CrossRef] [Google Scholar]
  • Stanton AM, Lorenz TA, Pulverman CS, Meston CM. Heart rate variability: A risk factor for female sexual dysfunction. Applied Psychophysiology and Biofeedback. 2015;40:229–237. doi: 10.1007/s10484-015-9286-9.. [Abstract] [CrossRef] [Google Scholar]
  • Stein DJ, Phillips KA, Bolton D, Fulford KWM, Sadler JZ, Kendler KS. What is a mental/psychiatric disorder? From DSM-IV to DSM-V. Psychological Medicine. 2010;40:1759–1765. doi: 10.1017/S0033291709992261. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
  • Stein DJ, Westenberg HG, Liebowitz MR. Social anxiety disorder and generalized anxiety disorder: serotonergic and dopaminergic neurocircuitry. J Clin Psychiatry. 2002;63(Suppl 6):12–19. [Abstract] [Google Scholar]
  • Strub L. Potentiel d’applicabilité de la Mindfulness-Based Cognitive Therapy dans la prise en charge des troubles sexuels. Annales Médico-psychologiques, revue psychiatrique. 2013;171:105–109. doi: 10.1016/j.amp.2013.01.002. [CrossRef] [Google Scholar]
  • Sunderland M, Slade T, Carragher N, Batterham P, Buchan H. Age-related differences in internalizing psychopathology amongst the Australian general population. Journal of Abnormal Psychology. 2013;122:1010–1020. doi: 10.1037/a0034562. [Abstract] [CrossRef] [Google Scholar]
  • ter Kuile MM, Both S, van Lankveld JJDM. Cognitive behavioral therapy for sexual dysfunctions in women. Psychiatry Clinics of North America. 2010;33:595–610. doi: 10.1016/j.psc.2010.04.010. [Abstract] [CrossRef] [Google Scholar]
  • ter Kuile MM, Both S, Van Uden J. The Effects of Experimentally-Induced Sad and Happy Mood on Sexual Arousal in Sexually Healthy Women. The Journal of Sexual Medicine. 2010;7:1177–1184. doi: 10.1111/j.1743-6109.2009.01632.x. [Abstract] [CrossRef] [Google Scholar]
  • Testa M, Collins RL. Alcohol and risky sexual behavior: Event-based analyses among a sample of high-risk women. Psychology of Addictive Behaviors. 1997;11:190. [Google Scholar]
  • Tiefer L. Beyond the medical model of women’s sexual problems: A campaign to resist the promotion of ‘female sexual dysfunction’ Sexual and Relationship Therapy. 2002;17:127–135. doi: 10.1080/14681990220121248. [CrossRef] [Google Scholar]
  • Tignol J, Martin-Guehl C, Aouizerate B, Grabot D, Auriacombe M. Social phobia and premature ejaculation: a case–control study. Depression and Anxiety. 2006;23:153–157. doi: 10.1002/da.20159. [Abstract] [CrossRef] [Google Scholar]
  • Trudel G, Marchand A, Ravart M, Aubin S, Turgeon L, Fortier P. The effect of a cognitive-behavioral group treatment program on hypoactive sexual desire in women. Sexual and Relationship Therapy. 2001;16:145–164. doi: 10.1080/14681990120040078. [CrossRef] [Google Scholar]
  • Vaidyanathan U, Patrick CJ, Cuthbert BN. Linking Dimensional Models of Internalizing Psychopathology to Neurobiological Systems: Affect-Modulated Startle as an Indicator of Fear and Distress Disorders and Affiliated Traits. Psychological Bulletin. 2009;135:909–942. doi: 10.1037/a0017222. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
  • van den Hout M, Barlow DH. Attention, arousal and expectancies in anxiety and sexual disorders. Journal of Affective Disorders. 2000;61:241–256. doi: 10.1016/S0165-0327(00)00341-4. [Abstract] [CrossRef] [Google Scholar]
  • van Lankveld JJDM, Grotjohann Y. Psychiatric comorbidity in heterosexual couples with sexual dysfunction assessed with the Composite International Diagnostic Interview. Archives of Sexual Behavior. 2000;29:479–498. doi: 10.1023/A:1001995704034. [Abstract] [CrossRef] [Google Scholar]
  • van Minnen A, Kampman M. The interaction between anxiety and sexual function: A controlled study of sexual functioning in women with anxiety disorders. Sexual and Relationship Therapy. 2000;15:47–57. doi: 10.1080/14681990050001556. [CrossRef] [Google Scholar]
  • Veith RC, Lewis N, Linares OA, Barnes RF, Raskind MA, Villacres EC, et al. Sympathetic nervous system activity in major depression: Basal and desipramine-induced alterations in plasma norepinephrine kinetics. Archives of General Psychiatry. 1994;51:411–422. doi: 10.1001/archpsyc.1994.03950050071008. [Abstract] [CrossRef] [Google Scholar]
  • Vilarinho S, Laja P, Carvalho J, Quinta-Gomes AL, Oliveira C, Janssen E, Nobre PJ. Affective and Cognitive Determinants of Women’s Sexual Response to Erotica. The Journal of Sexual Medicine. 2014;11:2671–2678. doi: 10.1111/jsm.12667. [Abstract] [CrossRef] [Google Scholar]
  • Villacres EC, Hollifield M, Katon WJ, Wilkinson CW, Veith RC. Sympathetic nervous system activity in panic disorder. Psychiatry Research. 1987;21:313–321. doi: 10.1016/0165-1781(87)90015-1. [Abstract] [CrossRef] [Google Scholar]
  • Vlachopoulos C, Aznaouridis K, Ioakeimidis N, Rokkas K, Vasiliadou C, Alexopoulos N, Stefanadis C. Unfavourable endothelial and inflammatory state in erectile dysfunction patients with or without coronary artery disease. European Heart Journal. 2006;27(22):2640–2648. [Abstract] [Google Scholar]
  • Vollebergh W, Iedema J, Bijl R, de Gråaf R, Smit F, Ormel J. The structure and stability of common mental disorders: the NEMESIS study. Archives of General Psychiatry. 2001;58:597–603. doi: 10.1001/archpsyc.58.6.597. [Abstract] [CrossRef] [Google Scholar]
  • Vreeburg SA, Zitman FG, van Pelt J, DeRijk RH, Verhagen JCM, van Dyck R, Penninx BWJH. Salivary Cortisol Levels in Persons With and Without Different Anxiety Disorders. Psychosomatic Medicine. 2010;72:340–347. doi: 10.1097/PSY.0b013e3181d2f0c8. [Abstract] [CrossRef] [Google Scholar]
  • Vulink N, Denys D, Bus L, Westenberg H. Sexual pleasure in women with obsessive-compulsive disorder? Journal of Affective Disorders. 2006;91:19–25. doi: 10.1016/j.jad.2005.12.006. [Abstract] [CrossRef] [Google Scholar]
  • Waldinger MD. The nerobiological approach to premature ejaculation. Journal of Urology. 2002;168:2359–2367. doi: 10.1097/01.ju.0000035599.35887.8f. [Abstract] [CrossRef] [Google Scholar]
  • Watts G, Nettle D. The Role of Anxiety in Vaginismus: A Case-Control Study. The Journal of Sexual Medicine. 2010;7:143–148. doi: 10.1111/j.1743-6109.2009.01365.x. [Abstract] [CrossRef] [Google Scholar]
  • Weisberg RB, Brown TA, Wincze JP, Barlow DH. Causal attributions and male sexual arousal: the impact of attributions for a bogus erectile difficulty on sexual arousal, cognitions, and affect. J Abnorm Psychol. 2001;110:324–334. [Abstract] [Google Scholar]
  • Wiegel M, Scepkowski LA, Barlow DH. Cognitive-affective processes in sexual arousal and sexual dysfunction. In: Janssen E, editor. The psychophysiology of sex. Indiana University Press; Bloomington: 2007. pp. 143–165. [Google Scholar]
  • Williams K, Abraham L, Symonds T. Psychometric validation of an abbreviated version of the Sexual Function Questionnaire (ASFQ) Value in Health. 2010;13:A381. doi: 10.1016/S1098-3015(11)72548-7. [CrossRef] [Google Scholar]
  • Williams K, Reynolds MF. Sexual dysfunction in major depression. CNS spectrums. 2006;11:19–23. [Abstract] [Google Scholar]
  • Wilson A. Disinhibition and narrative in the paraphilias. Progress in neuro-psychopharmacology & biological psychiatry. 2010;34:431. doi: 10.1016/j.pnpbp.2010.01.001. [Abstract] [CrossRef] [Google Scholar]
  • Wincze JP, Weisberg RB. Sexual dysfunction: A guide for assessment and treatment. Guilford Publications; 2015. [Google Scholar]
  • Wolpe J. Psychotherapy by Reciprocal Inhibition. Stanford, CA: Stanford University Press; 1958. [Google Scholar]
  • World Health Organization. ICD – 10: International statistical classification of diseases and related health problems. 10th. New York: World Health Organization; 2008. Rev ed. [Google Scholar]
  • Wright AG, Simms LJ. A metastructural model of mental disorders and pathological personality traits. Psychological Medicine. 2015;45:2309–2319. doi: 10.1017/S0033291715000252. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
  • Yehuda R, Lehrner A, Rosenbaum TY. PTSD and Sexual Dysfunction in Men and Women. The Journal of Sexual Medicine. 2015;12:1107–1119. doi: 10.1111/jsm.12856. [Abstract] [CrossRef] [Google Scholar]
  • Young JE, Klosko JS, Weishaar ME. Schema therapy: A practitioner’s guide. Guilford Press; 2003. [Google Scholar]
  • Zemishlany Z, Weizman A. The impact of mental illness on sexual dysfunction. Advances in Psychosomatic Medicine. 2008;29:89–106. doi: 10.1159/000126626. [Abstract] [CrossRef] [Google Scholar]
Comments are closed.